JPH047329B2 - - Google Patents
Info
- Publication number
- JPH047329B2 JPH047329B2 JP57215858A JP21585882A JPH047329B2 JP H047329 B2 JPH047329 B2 JP H047329B2 JP 57215858 A JP57215858 A JP 57215858A JP 21585882 A JP21585882 A JP 21585882A JP H047329 B2 JPH047329 B2 JP H047329B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- group
- radioactive
- physiologically active
- dialdehyde starch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 claims description 124
- 230000002285 radioactive effect Effects 0.000 claims description 87
- 239000003446 ligand Substances 0.000 claims description 43
- 229920002085 Dialdehyde starch Polymers 0.000 claims description 34
- 230000001588 bifunctional effect Effects 0.000 claims description 34
- 239000003795 chemical substances by application Substances 0.000 claims description 32
- 239000000203 mixture Substances 0.000 claims description 28
- 125000003277 amino group Chemical group 0.000 claims description 27
- 229910052751 metal Inorganic materials 0.000 claims description 26
- 239000002184 metal Substances 0.000 claims description 26
- 125000003172 aldehyde group Chemical group 0.000 claims description 15
- UBQYURCVBFRUQT-UHFFFAOYSA-N N-benzoyl-Ferrioxamine B Chemical class CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN UBQYURCVBFRUQT-UHFFFAOYSA-N 0.000 claims description 11
- 229940106780 human fibrinogen Drugs 0.000 claims description 11
- 229960000958 deferoxamine Drugs 0.000 claims description 10
- 230000000975 bioactive effect Effects 0.000 claims description 9
- 239000000969 carrier Substances 0.000 claims description 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 5
- 229920000642 polymer Polymers 0.000 claims description 4
- 230000009257 reactivity Effects 0.000 claims description 2
- 125000005647 linker group Chemical group 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 1
- 229940098197 human immunoglobulin g Drugs 0.000 claims 1
- 229920013730 reactive polymer Polymers 0.000 claims 1
- 239000000243 solution Substances 0.000 description 62
- 229940039227 diagnostic agent Drugs 0.000 description 29
- 239000000032 diagnostic agent Substances 0.000 description 29
- GYHNNYVSQQEPJS-OIOBTWANSA-N Gallium-67 Chemical compound [67Ga] GYHNNYVSQQEPJS-OIOBTWANSA-N 0.000 description 25
- 229940006110 gallium-67 Drugs 0.000 description 25
- 102000008946 Fibrinogen Human genes 0.000 description 18
- 108010049003 Fibrinogen Proteins 0.000 description 18
- 229940012952 fibrinogen Drugs 0.000 description 18
- 238000000034 method Methods 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 12
- 238000003745 diagnosis Methods 0.000 description 12
- 238000002372 labelling Methods 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 10
- GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 description 9
- 238000009206 nuclear medicine Methods 0.000 description 9
- 229940056501 technetium 99m Drugs 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 208000007536 Thrombosis Diseases 0.000 description 7
- 150000002739 metals Chemical class 0.000 description 7
- 206010053567 Coagulopathies Diseases 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000003638 chemical reducing agent Substances 0.000 description 6
- 230000035602 clotting Effects 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- -1 halogen anions Chemical class 0.000 description 5
- 229910021645 metal ion Inorganic materials 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- OUDSFQBUEBFSPS-UHFFFAOYSA-N ethylenediaminetriacetic acid Chemical compound OC(=O)CNCCN(CC(O)=O)CC(O)=O OUDSFQBUEBFSPS-UHFFFAOYSA-N 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 229960003330 pentetic acid Drugs 0.000 description 4
- YEEGWNXDUZONAA-UHFFFAOYSA-K 5-hydroxy-2,8,9-trioxa-1-gallabicyclo[3.3.2]decane-3,7,10-trione Chemical compound [Ga+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YEEGWNXDUZONAA-UHFFFAOYSA-K 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 102000009123 Fibrin Human genes 0.000 description 3
- 108010073385 Fibrin Proteins 0.000 description 3
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 229950003499 fibrin Drugs 0.000 description 3
- SYECJBOWSGTPLU-UHFFFAOYSA-N hexane-1,1-diamine Chemical compound CCCCCC(N)N SYECJBOWSGTPLU-UHFFFAOYSA-N 0.000 description 3
- 229940027941 immunoglobulin g Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 230000004962 physiological condition Effects 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 235000010378 sodium ascorbate Nutrition 0.000 description 3
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 3
- 229960005055 sodium ascorbate Drugs 0.000 description 3
- 239000012279 sodium borohydride Substances 0.000 description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 description 3
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- PNDPGZBMCMUPRI-HVTJNCQCSA-N 10043-66-0 Chemical compound [131I][131I] PNDPGZBMCMUPRI-HVTJNCQCSA-N 0.000 description 2
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
- 108010006654 Bleomycin Proteins 0.000 description 2
- 208000031648 Body Weight Changes Diseases 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 102000008100 Human Serum Albumin Human genes 0.000 description 2
- 108091006905 Human Serum Albumin Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 229960001561 bleomycin Drugs 0.000 description 2
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000004579 body weight change Effects 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- APFVFJFRJDLVQX-AHCXROLUSA-N indium-111 Chemical compound [111In] APFVFJFRJDLVQX-AHCXROLUSA-N 0.000 description 2
- 229940055742 indium-111 Drugs 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000003541 multi-stage reaction Methods 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000011150 stannous chloride Nutrition 0.000 description 2
- 239000001119 stannous chloride Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- DPXXPADUUSWHIH-UHFFFAOYSA-N Cl.C(C)C1(C(NC(NC1=O)=O)=O)CC.[Na] Chemical compound Cl.C(C)C1(C(NC(NC1=O)=O)=O)CC.[Na] DPXXPADUUSWHIH-UHFFFAOYSA-N 0.000 description 1
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
- GYHNNYVSQQEPJS-YPZZEJLDSA-N Gallium-68 Chemical compound [68Ga] GYHNNYVSQQEPJS-YPZZEJLDSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- ASVIKLJUPUSDHT-UHFFFAOYSA-N [[3-(aminomethylidene)-4-(carbamothioylhydrazinylidene)pentan-2-ylidene]amino]thiourea Chemical class NC(=S)NN=C(C)C(=CN)C(C)=NNC(N)=S ASVIKLJUPUSDHT-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 229960002319 barbital Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229910052713 technetium Inorganic materials 0.000 description 1
- GKLVYJBZJHMRIY-UHFFFAOYSA-N technetium atom Chemical compound [Tc] GKLVYJBZJHMRIY-UHFFFAOYSA-N 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- BKVIYDNLLOSFOA-OIOBTWANSA-N thallium-201 Chemical compound [201Tl] BKVIYDNLLOSFOA-OIOBTWANSA-N 0.000 description 1
- 150000003584 thiosemicarbazones Chemical class 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Description
ïŒç£æ¥äžã®å©çšåéïŒ
æ¬çºæã¯ãéæŸå°æ§ãã€ãªã€ãŒã該ãã€ãªã€ãŒ
å«æã»æŸå°æ§èšºæå€è£œé çšã®çµæç©ãããã³è©²ã
ã€ãªã€ãŒå«æã»æŸå°æ§èšºæå€ã«é¢ããããããé
æŸå°æ§ãã€ãªã€ãŒã¯ããžã¢ã«ããããã³ãã³ãä»
ãïŒå®èœé äœåååç©ãšçç掻æ§ååç©ãçµåã
ãŠãªããæç®æªèšèŒã®æ°èŠååç©ã§ããã æ¬çºæã®æŸå°æ§èšºæå€ã¯ãç¹å®èåšã®æåºãç¹
å®çŸæ£ã®æ€åºããã³çç掻æ§ååç©ã®åæ æ€æ»ãª
ã©ãç®çãšããæ žå»åŠççšéã«æçšã§ããã ïŒåŸæ¥ã®æè¡ïŒ çŸåšãé浞襲çæ žå»åŠèšºæã®ããã«çš®ã ã®æŸå°
æ§æšèååç©ãéçºãããæŸå°æ§èšºæå€ãšããŠèš
åºäžãã®æçšæ§ãé«ãèªããããŠãããäžè¬ã«ã
æŸå°æ§æšèååç©ã¯ãçäœå ãžã®å°å ¥åŸãç¹å®è
åšãç¹å®çŸæ£éšäœã«ç¹ç°çãªéç©æ§ã瀺ãããã
çäœå ã«ãããçççãªè«žç¶æ ã«å¯Ÿå¿ããç¹ç°ç
ãªåæ ããšãããšãèŠæ±ãããã æšèååç©ã«äœ¿çšãããæŸå°æ§éå±ãšããŠãåŸ
æ¥ãå ±æçµåã«ãããšãŒãâ131ã®ã»ãã«ãé äœ
çµåçã«ããæŸå°æ§éå±ãæ±çšãããããäŸã
ã°ããã¯ãããŠã â99ïœãã¬ãªãŠã â67ãã€ã³ãž
ãŠã â111çã§ãããããããã®æŸå°æ§éå±ã¯æ ž
å»åŠç蚺æã«ããé©ããç©æ§ã瀺ãããŸããæšè
ãããçç掻æ§ååç©ããŠããè¡æž ã¢ã«ããã³ã
ãã¬ãªãã€ã·ã³ããã€ããªããŒã²ã³ãªã©ãçšãã
ãããã«ãã¬ãªãŠã â67ãªã©ã®æŸå°æ§éå±ããçŽ
æ¥å°å ¥ããããšããè©Šã¿ããªãããŠããã ããããããã¯çç掻æ§ååç©ã®ãã¬ãŒã圢æ
æ§ã¯å¿ ããã倧ãããªãããŸã調補ãããæšèå
åç©ã®äœå æäžåŸã®å®å®æ§ãäœããããã«æŸå°èœ
ã®äœå æåãšãã®çç掻æ§ååç©ã®æåãäžèŽã
ãªãçãæ žå»åŠèšºæãç®çãšããçšéã«ãããŠã
æºè¶³ãã¹ããã®ã§ã¯ãªãã æ¬æ现æžã«ãããŠçšãããããçç掻æ§åå
ç©ããªãèªã¯ãç¹å®èåšãŸãã¯ç¹å®çŸæ£éšäœã«ç¹
ç°çãªéç©æ§ã瀺ãããçäœå ã«ãããçççãª
è«žç¶æ ã«å¯Ÿå¿ããç¹ç°çãªåæ ããšããããªãã®
ã§ãã€ãŠããã®äœå æåã远跡ããããšã«ããã
åçš®ã®èšºæã«æçšãªæ å ±ãæäŸãããååç©ãæ
å³ããããã®ãããªçç掻æ§ååç©ã«ãåªããç©
æ§ãæããæŸå°æ§éå±ãå®å®ã«ãããã該ååç©
ã®çç掻æ§ããããªãããšãªãå°å ¥ããããšãã§
ããã°ãæ žå»åŠèšºæã«ãããŠã極ããŠæçšãªçšé
ãæåŸ ããããè¿å¹ŽãïŒå®èœé äœåååç©ãçšã
ãæ¹æ³ãææ¡ãããã ããªãã¡ããããæ¹æ³ã¯ãïŒå®èœé äœåååç©
ã®åçš®éå±ã«å¯Ÿãã匷ããã¬ãŒã圢æèœãããã
é äœåååç©ã®æ«ç«¯åºïŒã¢ããåºããã³ã«ã«ãã
ã·ã«åºïŒã®çç掻æ§ååç©ã«å¯Ÿããåå¿æ§ãå©çš
ãã該æŸå°æ§éå±ãšè©²çç掻æ§ååç©ãããã®é
äœåååç©ãä»ããŠçµåãããããšãããªããã®
ã§ã該é äœåååç©ãšããŠãžãšãã¬ã³ããªã¢ãã³
äºé ¢é žïŒDTPAïŒããšãã¬ã³ãžã¢ãã³äžé ¢é ž
ïŒEDTAïŒãïŒâãªããœããã©ãŒã«ãã¹ïŒïŒ®âã¡
ãã«ããªã»ãã«ã«ããŸã³ïŒã«ã«ãã³é žããããšã
ããµãã³ãïŒâã¢ããã¡ãã¬ã³âïŒïŒïŒâãã³ã¿
ã³ãžãªã³ãã¹ïŒããªã»ãã«ã«ããŸã³ïŒèªå°äœãã
ã³ïŒâïŒïœâã¢ããã¢ã«ãã«ïŒããšãã«ãããã³
âïŒïŒïŒâãžãªã³âãã¹ïŒïŒ®âã¡ãã«ããªã»ãã«
ã«ããŸã³ïŒèªå°äœçãå ±åãããŠããïŒG.E.
KrejcarekïŒBiochemicalïŒBiophysical
Research Communication77 2.581â585
1977ïŒC.S.ïŒLeungïŒInt.J.Appl.RadiationïŒ
Isotope29 687â692 1978ãç¹éæ56â34634ã
ç¹éæ56â125317ãç¹éæ57â102820ãç¹é¡æ57
â157372åç §ïŒããããã®æ¹æ³ã«ããã°ããŸãïŒ
å®èœé äœåååç©ãšçç掻æ§ååç©ãçµåãããŠ
éæŸå°æ§ãã€ãªã€ãŒã調補ãããã®ãã€ãªã€ãŒã«
察ãæŸå°æ§éå±ãè£è¶³ãããŠãããåŸãããæšè
ååç©ã¯ãäžè¬çã«ã¯æ¯èŒçå®å®ã§ãã€ãŠçç掻
æ§ååç©ã®æŽ»æ§ãä¿æãããã®ã§ãããæ žå»åŠèšº
æã«ãããæŸå°æ§èšºæå€ãšããŠéåžžã«èå³ã®ãã
è¬å€ã§ããã ïŒçºæã解決ããããšãã課é¡ïŒ ããããªããããããå ¬ç¥ã®ãéæŸå°æ§ãã€ãª
ã€ãŒãçšããæŸå°æ§èšºæå€ã®æ倧ã®æ¬ ç¹ã¯ãçç
掻æ§ååç©ãšããŠãè¡æ 蚺æçšã®ãã€ããªããŒã²
ã³ïŒååéçŽ34äžïŒãã¬ã³èšºæçšã®å ç«ã°ãããª
ã³ïŒ§ïŒIgGïŒïŒååéçŽ16äžïŒã®ãããªãååéã®
倧ããªãã®ãçšããå Žåãçžå¯Ÿçã«éå±ã®å ãã
å²åãäœäžãããã®çµæã蚺æã«å¿ èŠãªæŸå°èœã¬
ãã«ãåŸãããªãããšã§ããã ãã®ïŒã€ã®è§£æ±ºæ³ãšããŠãçç掻æ§ååç©ïŒå
åã«å¯Ÿãå€æ°ã®ïŒå®èœé äœåååç©ãçµåããã
次ãã§ã§ãã®å€æ°ã®ïŒå®èœé äœååã ã«æŸå°æ§é
å±ãé äœãããããšã«ããé«æ¯æŸå°èœã®ãã®ãåŸ
ãæ¹æ³ãèãããããããããã®æ¹æ³ã¯ãçç掻
æ§ååç©ãå€æ§ãããããã®æŽ»æ§ãäœäžãæ¶æ» ã
ããçµæãšãªãã奜ãŸãããªããä»æ¹ãäžè¬ã«å
åéã®å€§ããçç掻æ§ååç©ãçšããå Žåããã®
æåæ§ã®èŠ³ç¹ãããã§ããã ãæäžéãå°éã«ã
ãããšãæãŸããŠããããã®ãã«ããåŸæ¥ããã®
éæŸå°æ§ãã€ãªã€ãŒã«ä»£ãããé«æ¯æŸå°èœã®æŸå°
æ§èšºæå€è£œé çšã»ååç©ã®åºçŸãæãŸããŠããã®
ã§ããã ïŒèª²é¡ã解決ããããã®ææ®µïŒ æ¬çºæè ãã¯ã以äžã®åé¡ç¹ã解決ãã¹ãçš®ã
ã®èŠ³ç¹ããæ€èšãå ããçµæããžã¢ã«ããããã³
ãã³ãšïŒå®èœé äœåååç©ãšçç掻æ§ååç©ãšã
ããªãæ°èŠãªååç©ã®éçºã«æåããã®ã§ããã ããªãã¡æ¬çºæã¯ã(1)å°ãªããïŒã€ã®éé¢ã¢ã«
ãããåºãæãããžã¢ã«ããããã³ãã³ïŒååãš
ã¢ããåºå«æïŒå®èœé äœåååç©å°ãªããšãïŒå
åãçµåããŠãªãå°ãªããšãïŒã€ã®éé¢ã¢ã«ãã
ãåºãæããåå¿æ§é«ååååç©ãšãã¢ããåºå«
æçç掻æ§ååç©ãšãããªãååç©ã§ãã€ãŠã該
ãžã¢ã«ããããã³ãã³ãšè©²ïŒå®èœé äœåã®çµååº
ããã³è©²ãžã¢ã«ããããã³ãã³ãšè©²çç掻æ§åå
ç©ã®çµååºããåã âCHïŒïŒ®âåºãŸãã¯âCH2
âNHâåºã§ããéæŸå°æ§ãã€ãªã€ãŒã(2)該ãã€
ãªã€ãŒå«ææŸå°æ§èšºæå€è£œé çšã®çµæç©ãããã³
(3)該ãã€ãªã€ãŒå«ææŸå°æ§èšºæå€ãæäŸãããã®
ã§ããã ãããæ°èŠãªéæŸå°æ§ãã€ãªã€ãŒãçšããã°ã
çç掻æ§ååç©ãå€æ§ããããã¯æŽ»æ§äœäžããã
ããšãªãé«æ¯æŸå°èœã®æŸå°æ§èšºæå€ã補é ããã
ãšãã§ããã ïŒäœçšïŒ æ¬çºæã®éæŸå°æ§ãã€ãªã¢ã¯ãçžå¯Ÿçã«å°æ°ã®
çç掻æ§ååç©ãšå€æ°ã®ïŒå®èœé äœåååç©ãã
ãžã¢ã«ããããã³ãã³ãä»ããŠçµåããååç©ã§
ãããïŒååãããå€æ°ã®éå±åœ¢æéšäœïŒé äœ
åïŒã該ïŒå®èœé äœåååç©éšåäžã«æãããã
ãªãã¡ã該ãã€ãªã€ãŒã¯ãïŒååã«å¯Ÿãçµåãã
ãæŸå°æ§éå±ã€ãªã³ã®æ°ããåã«ïŒå®èœé äœåå
åç©ãå°å ¥ããåŸæ¥ããã®ãã€ãªã¢ãšæ¯èŒãã
ãšãæ Œæ®µã«å€ãç¹ã§ç¹åŸŽä»ãããããããããã
ãæŸå°æ§éå±ãšçç掻æ§ååç©ããïŒã€ã®ååç©
ïŒïŒå®èœé äœåååç©ïŒãžã¢ã«ããããã³ãã³ïŒ
ãä»ããŠçµåããŠããããã該çç掻æ§ååç©ã®
å€æ§ã掻æ§äœäžãèµ·ããã«ãç®çãšããé«æ¯æŸå°
èœã®æŸå°æ§èšºæå€ãåŸãããšãã§ããã®ã§ããã ïŒçºæã®è©³èª¬ïŒ æ¬çºæã®éæŸå°æ§ãã€ãªã€ãŒã¯ããžã¢ã«ããã
ãã³ãã³ã®ã¢ã«ãããåºãïŒå®èœé äœåååç©ã
ãã³çç掻æ§ååç©ã®åã¢ããåºãšçµåããŠãª
ãã æ¬çºæã®å¥ã®æ æ§ã§ãã該æŸå°æ§èšºæå€è£œé çš
ã®çµæç©ã¯ãå¿ é æåãšããŠäžèšéæŸå°æ§ãã€ãª
ã€ãŒãå«æããã æ¬çºæã®ããïŒã€å¥ã®æ æ§ã§ããæŸå°æ§éå±æš
èã€ãæŸå°æ§èšºæå€ã¯ãå¿ é æåãšããŠäžèšéæŸ
å°æ§ãã€ãªã€ãŒãšæŸå°æ§éå±ãå«æããã æ¬çºæã«çšãããããžã¢ã«ããããã³ãã³ã¯ã
ãã³ãã³ãåæãšããŠéãšãŠçŽ é žçé©åœãªé žåå€
ã§é žåããããšã«ããäœããã代衚çã«ã¯åäœå
åäžã«å®èœåºãšããŠïŒã€ã®ã¢ã«ãããåºããã€é
ç¶é«ååã§ãããåžè²©ãããŠãããã®ã§ãããã
ã®å埩åäœæ°ã¯ãïŒã1000ã奜ãŸããã¯10ã500
ã§ããã æ¬çºæã«çšããããïŒå®èœé äœåååç©ã¯ã
çš®ã ã®æŸå°æ§éå±ãšã®åŒ·ããã¬ãŒã圢æèœãšã¢ã«
ãããåºãšç©åãªæ¡ä»¶äžã§çµåããèœåãæãã
ã¢ããåºãæã€ååç©ã§ã§ããã°ããããã§ãã
ãããŸãããããã¢ããåºã«ä»£ããŠã«ã«ããã·ã«
åºãæã€ååç©ã«ãããŠãããã®ã«ã«ããã·ã«åº
ããããµã³ãžã¢ãã³çã«ããã¢ããåºã«å€ããã¢
ã«ãããåºãšç©åãªæ¡ä»¶ã§çµåããèœåãæãã
ãããšã«ãããæ¬çºæã«äœ¿çšããããšãã§ããã
ãããïŒå®èœé äœåååç©ãšããŠãäŸãã°ããã
ãšãããµãã³ãïŒâã¢ããã¡ãã¬ã³âïŒïŒïŒâã
ã³ã¿ã³ãžãªã³âãã¹ïŒããªã»ã«ã«ã«ããŸã³ïŒèªå°
äœãïŒâïŒïœâã¢ããã¢ã«ãã«ïŒããšãã«ããã
ã³âïŒïŒïŒâãžãªã³âãã¹ïŒããªã»ãã«ã«ããŸ
ã³ïŒèªå°äœçã®æ«ç«¯ã¢ããåºå«æïŒå®èœé äœåå
åç©ãªãã³ã«ããžãšãã¬ã³ããªã¢ãã³äºé ¢é ž
ïŒDTPAïŒããšãã¬ã³ãžã¢ãã³äžé ¢é žïŒEDTAïŒã
ïŒâãªããœããã©ãŒã«ãã¹ïŒïŒ®âã¡ãã«ããªã»ã
ã«ã«ããŸã³ïŒã«ã«ãã³é žã®ãããªæ«ç«¯ã¢ããåºå«
æååç©ã«èªå°å¯èœãªïŒå®èœé äœåååç©ãæã
ãããã æ¬çºæã®ã¢ããåºå«æïŒå®èœé äœåååç©ã¯ã
ãããã¢ããåºããžã¢ã«ããããã³ãã³ã®ã¢ã«ã
ããåºãšãâCHïŒïŒ®âåºãŸãã¯âCH2âNHâåº
ãä»ããŠçµåããããžã¢ã«ããããã³ãã³ïŒåå
ã«å¯ŸããŠçµåããïŒå®èœé äœåååç©ã®ååæ°
ã¯ãïŒä»¥äžã代衚çã«ã¯ïŒä»¥äžã奜ãŸããã¯10以
äžã§ããã æ¬çºæã«çšããããçç掻æ§ååç©ã¯ãç¹å®è
åšãŸãã¯ç¹å®çŸæ£éšäœã«ç¹ç°ãªéç©æ§ã瀺ãããŸ
ãã¯ãçäœå ã«ãããçççãªè«žç¶æ ã«å¯Ÿå¿ãã
ç¹ç°ãªåæ ããšãããã®äœå æåã远跡ããããš
ã«ãããåçš®ã®èšºæã«æçšãªæ å ±ãæäŸããããš
ãæåŸ ããããããªååç©ã§ãããç¹ã«ãæ¬çºæ
ã®å®çšæ§ãèæ ®ãããšãååéçŽ10äžä»¥äžã®çç
掻æ§ååç©ã«ãããŠããã®æçšæ§ã奜é©ã«çºæ®ã
ããã該ååç©ãšããŠãäŸãã°ãããè¡æž ã¢ã«ã
ãã³ããã€ããªããŒã²ã³ããŠããããŒãŒãå ç«æ
äœã§ããIgGã®åŠãã¿ã³ãã¯ããã¬ãªãã€ã·ã³ã
ã«ããã€ã·ã³ã®åŠãæçç©è³ªããã«ã¢ã³é¡ãç³
é¡ãèèªé žããã³ãããã®èªå°äœãæããããã ãŸããã¢ããåºãæããªãçç掻æ§ååç©ã®å Ž
åã«ã¯ãé©åœãªæ¹æ³ã«ããã¢ããåºãå°å ¥ããã
ãšã«ãããæ¬çºæã®çç掻æ§ååç©ãšããŠäœ¿çšã§
ããã æ¬çºæã®ã¢ããåºå«æçç掻æ§ååç©ã¯ããã
ãã¢ããåºããžã¢ã«ããããã³ãã³ã®ã¢ã«ããã
åºãšãâCHïŒïŒ®âåºãŸãã¯âCH2âNHâåºãä»
ããŠçµåããããžã¢ã«ããããã³ãã³ïŒååã«å¯Ÿ
ããŠçµåããçç掻æ§ååç©ã®ååæ°ã¯ã奜ãŸã
ãã¯ãå°ãªããšã10以äžããã奜ãŸããïŒä»¥äžã«
ãã¹ãã§ããã æ¬çºæã«äœ¿çšãããæŸå°æ§éå±ã¯ãæ žå»åŠèšºæ
ã«é©ããç©ççç¹æ§ãæããïŒå®èœé äœåååç©
ãšå®å®ãªãã¬ãŒãã圢æããæŸå°æ§éå±ã§ããã°
ãããäŸãã°ãã¬ãªãŠã â67ãã¬ãªãŠã â68ãã€
ã³ãžãŠã â111ãã¿ãªãŠã â201ããã¯ãããŠã â
99mãªã©ãçŸåšãæ žå»åŠåéã§æ±çšãããŠããæŸ
å°æ§éå±ãæããããšãã§ããããã ããéãã¯
ãããŠã é žå¡©ã®åœ¢ã§åžè²©ãããŠãããã¯ãããŠã
â99mãªã©ã®æŸå°æ§éå±ã€ãªã³ã®ããã«ãå ¥æã
ããŸãŸã®åå䟡ç¶æ ã§ã¯åè¿°ã®ïŒå®èœé äœååå
ç©ãšåŒ·åºã«çµåããªãå Žåããã®ãããªæŸå°æ§é
å±ã€ãªã³ãã匷åºãªçµåã®åœ¢æã«æå©ãªäœåå䟡
ç¶æ ã«éå ãããã«éåžžçšããããŠãã第äžã¹ãº
å¡©çã®éå å€ãããããããæ¬çºæã«ããæŸå°æ§
蚺æå€èª¿è£œçšã®çµæç©äžã«å«æãããŠããã°æ¬çº
æãå®æœãããã 次ã«ãæ¬çºæã®éæŸå°æ§ãã€ãªã€ãŒã®è£œé ã«ã€
ããŠã¯ããžã¢ã«ããããã³ãã³ã®ã¢ã«ãããåº
ãšãïŒå®èœé äœåååç©ããã³çç掻æ§ååç©ã®
ã¢ããåºãåå¿ãããŠç®çç©ãåŸãããšãã§ãã
ããããã«ããã®åå¿çæç©ãæ°ŽçŽ åããŠçŽ ãã
ãªãŠã ã®ãããªéå å€ã§éå ããããšã«ãã€ãŠã
åŸãããšãã§ããããžã¢ã«ããããã³ãã³ãšåå¿
ãããïŒå®èœé äœåååç©ããã³çç掻æ§ååç©
ã®åå¿ã®é çªã¯ä»»æã§ããããŸãåå¿ã®äžéã«ã
ããŠäžèšéå æäœããããããšãã§ããããã
ã«ã段éçåå¿ã®å Žåãå段éåå¿ã®çµäºæã«äž
éäœã®åé¢ã粟補æäœãå ããããšãä»»æã§ã
ããåå¿çµäºåŸã該çç掻æ§ååç©ã®ååŠçãç©
çã«å¿ããŠãã«ã©ã ã¯ãããã°ã©ãæ³ãã²ã«ãé
æ³ããã³éææ³ãªã©ã®ä»»æã®æ¹æ³ã«ãã粟補ãã
ããšãã§ããã 次ã«ã以äžã®åå¿çµè·¯ã«åŸããæ¬çºæã®éæŸå°
æ§ãã€ãªã€ãŒã®ä»£è¡šçãªè£œæ³ã説æããã åŒäžãããã³ïŒ¹ã¯ãããããïŒå®èœé äœåå
åç©ããã³çç掻æ§ååç©ã®ã¢ããåºåå¿æ®åºã
ã¯âCHOãŸãã¯âCH2OHãïœã¯ïŒã1000ã®æŽ
æ°ãïœããã³ïœã¯ãããããïŒã1000ã®æŽæ°ãïœ
ããã³ïœã¯ãããããïŒã1000ã®æŽæ°ã§ãããã
ã ããïœïŒïœããã³ïœïŒïœïŒïœã¯ïŒã1000ã§ã
ãã äžèšåå¿çµè·¯ã§ã¯ãçŽéç¶ã®éæŸå°æ§ãã€ãªã¢
ã®ã¿ã瀺ããããçç掻æ§ååç©ãæ«ç«¯ã¢ããåº
ãïŒå以äžæã€å Žåããã®çç掻æ§ååç©ãæ¶æ©
ç©è³ªãšãªããããªæ¶æ©é«ååååç©ãå¯çããã
ãã®æ¶æ©é«ååååç©ãæ¬çºæã®å®æœãäœã劚ã
ãªãããŸããæ¬çºæã®éæŸå°æ§ãã€ãªã€ãŒã«ãã
ãŠãçç掻æ§ååç©ãšïŒå®èœé äœåååç©ã®çµå
ç¶æ ã¯ããžã¢ã«ããããã³ãã³ãä»ããéæ¥çãª
çµåã§ãããããã®çµåã«å ããŠãçŽæ¥çãªçµå
ãããããååç©ååç©ã®çç掻æ§ãæãªããªã
éãã蚱容ããããã®ã§ããã 次ã«ãæ¬çºæã®ç¬¬ïŒã®æ æ§ã§ããæŸå°æ§èšºæå€
調補çšçµæç©ã®è£œé æ³ã«ã€ããŠè¿°ã¹ããæ¬çµæç©
ã¯ãåèšã®æ¹æ³ã«ããåŸãããéæŸå°æ§ãã€ãªã¢
ãç¡èæ°Žãççé£å¡©æ¶²ãå皮緩è¡æ¶²ã«æº¶è§£ããã
ãšã«ãã調補ãããããŸããå¿ èŠã«å¿ããéæŸå°
æ§ãã€ãªã¢ã®æº¶è§£æ§ãå¢ãããã®ææ©æº¶åªãPHã
調補ãããã®é žãå¡©åºã®æ·»å ãæŸå°æ§éå±ã€ãªã³
ã®åå䟡ç¶æ ã調æŽãããã®éå å€ãŸãã¯é žåå€
ã®æ·»å ãããã³å®å®åå€ãç匵åå€ãä¿åå€ã®æ·»
å ãããŠãããããããéå å€ã¯ãè¬å€åŠäžèš±å®¹
ããã氎溶æ§éå å€ã䜿çšããããã奜ãŸããã¯
第äžã¹ãºå¡©ãæãããããæ¬çºæã®å®æœã«ãããŠ
æçšãªç¬¬äžã¹ãºå¡©ã¯ãäºäŸ¡ã®ã¹ãºã圢æããå¡©ã§
ãã€ãŠãå ·äœçã«ã¯äŸãã°ãå¡©çŽ ã€ãªã³ãããçŽ
ã€ãªã³ãªã©ã®ããã²ã³é°ã€ãªã³ãç¡«é žã€ãªã³ãç¡
é žã€ãªã³ãªã©ã®è€çŽ ç¡æ©é žæ®åºã€ãªã³ãé ¢é žã€ãª
ã³ãã¯ãšã³é žã€ãªã³ãªã©ã®ææ©é žæ®åºã€ãªã³ãšåœ¢
æããå¡©ãèšãã éæŸå°æ§ãã€ãªã¢ã®éã¯ãæçµçã«è£œé ããã
æŸå°æ§èšºæå€ã®æšèçãå®çšäžæ¯éã®ãªãçšåºŠã«
é«ããªããããªéã§ããã°ããããã€è¬å€åŠäžèš±
容ãããç¯å²ã§ããããšãæãŸããããšã¯ãããŸ
ã§ããªãããŸããææã«ããå ãããã第äžã¹ãº
å¡©çã®éå å€ã«ã€ããŠã¯ãæŸå°æ§éå±ã€ãªã³ãé©
åœãªåå䟡ç¶æ ã«éå ããã®ã«å åãªéã§ããã
ãè¬å€åŠäžèš±å®¹ãããç¯å²ã§ããã°ããã åŸãããéæŸå°æ§çµæç©ã¯ããã®ãŸãŸæº¶æ¶²ã®åœ¢
ã§æŸå°æ§éå±ã«ããæšèåã«äŸããŠãããããŸ
ããåçµä¹Ÿç¥æ³ãŸãã¯äœæž©å§èžçºæ³ãªã©ã®æ¹æ³ã«
ãã溶åªãé€å»ãã也ç¥åã®åœ¢ã«ããåŸãæŸå°æ§
éå±ã«ããæšèåã«äŸããŠãããã æåŸã«ãæ¬çºæã®ç¬¬ïŒã®æ æ§ã§ããæŸå°æ§èšºæ
å€ã®è£œé æ³ã説æãããããã¯ãåèšã®éæŸå°æ§
ãã€ãªã¢ãŒãšæŸå°æ§éå±ãå«ã溶液ãæ¥è§Šããã
ããšãããªãã極ããŠç°¡åãªæäœã«ããã該蚺æ
å€ã補é ãããšãã§ããã æ¥è§ŠãããæŸå°æ§éå±ã®æŸå°èœã¯ä»»æã§ãã
ããç®çãšããæ žå»åŠèšºæãå®æœããã«éããŠã
å åãªæ å ±ãåŸããããããªæŸå°èœã§ãããã
ã€ã被éšè ã®æŸå°ç·è¢«æãå¯èœãªéãäœãããã
ããªæŸå°èœã®ç¯å²ã§ããããšãæãŸããã®ã¯ãã
ãŸã§ããªãã 該蚺æå€ã®æäžæ¹æ³ã«ã€ããŠã¯ãäžè¬ã«éèå
ãæäžãè¡ãªãããããæšèãããã¹ãçç掻æ§
ååç©ã®æäžåŸãã®æŽ»æ§ãçºçŸãããã«æå©ãªæ
äžæ¹æ³ã§ããã°ãããä»ã®æäžæ¹æ³ãå®æœããã
ãšãã§ããã ïŒå®æœäŸïŒ ã€ãã«å®æœäŸãæããŠãæ¬çºæãããã«è©³ãã
説æãããããããã«éå®ããããã®ã§ã¯ãªãã å®æœäŸ ïŒ éæŸå°æ§ãã€ãªã€ãŒããã³æŸå°æ§èšºæå€è£œé
çšã»çµæç©ã®è£œé (1) ïŒå®èœé äœåååç©ïŒãããšãããµãã³ïŒDFOïŒ çç掻æ§ååç©ïŒãããã€ããªããŒã²ã³ DFO130mgãPH8.4ã®0.01Mãªã³é žç·©è¡æ¶²â
0.15Mé£å¡©æ°Žæ··å溶液ïŒä»¥äžãPBSïŒ1.5mlã«æº¶
解ããããã®æº¶æ¶²ã«ãããªãšãã«ã¢ãã³ïŒ99ïŒ æº¶
液ïŒ27.9ÎŒãå ããçŽïŒåé宀枩ã§æªæããã
ããã«ããã®æº¶æ¶²ã«ãæ°Žã«æº¶è§£ãããžã¢ã«ããã
ãã³ãã³ïŒDASïŒ25mgïŒml溶液ãïŒmlå ãã15
åé宀枩ã§æªæããããã®æº¶æ¶²ã液ãšããã å¥ã«ããããã€ããªããŒã²ã³200mgãPBS30ml
ã«æº¶è§£ããããã®æº¶æ¶²ã液ãšãããïŒãïŒâã§
液3.5mlã液ã«å ããåã枩床ã§çŽïŒæéæª
æãåå¿ãããã åå¿çµäºåŸãåŸããã溶液ãã0.01MãããŠç³
â0.3Mã¯ãšã³é žãããªãŠã 溶液ïŒä»¥äžGLC溶液ïŒ
ã«å¯ŸããŠïŒãïŒâã§24æééæããã®ã¡ããã
ã«ãGLC溶液ã溶åºå€ãšããŠã»ãã¢ããŒã¹4B
ïŒ4.4ÏÃ50cmã«ã©ã ïŒã«ãããŠãæªåå¿è©Šè¬çã
é€å»ããç®çãšããéæŸå°æ§ãã€ãªã¢ãåŸãã ãã®æº¶æ¶²ãGLC溶液ã§åžéããŠãã€ããªããŒ
ã²ã³æ¿åºŠïŒmgïŒmlãšããããã«30mMã«ãªããã
ã«ã¢ã¹ã³ã«ãã³é žãããªãŠã ãå ãããã®ïŒmlã
ãã€ã¢ã«ã«å泚ããã®ã¡ãåçµä¹Ÿç¥ãè¡ã€ãŠæŸå°
æ§èšºæå€è£œé çšã®çµæç©ãåŸãã以äžã®æäœã¯å š
ãŠç¡èçã«è¡ãªã€ããåŸãããæŸå°æ§èšºæå€è£œé
çšã®çµæç©ã¯ç¶¿ç¶ã®åçµä¹Ÿç¥åã§ããã å®æœäŸ ïŒ éæŸå°æ§ãã€ãªã€ãŒããã³æŸå°æ§èšºæå€è£œé
çšã»çµæç©ã®è£œé (2) ïŒå®èœé äœåååç©ïŒDFO çç掻æ§ååç©ïŒãããã€ããªããŒã²ã³ DFO130mgãPBS1.5mlã«æº¶è§£ããããã®æº¶æ¶²
ã«ãããªãšãã«ã¢ãã³ïŒ99ïŒ æº¶æ¶²ïŒ27.9ÎŒãå
ããçŽïŒåé宀枩ã§æªæãããããã«ããã®æº¶æ¶²
ã«ãæ°Žã«æº¶è§£ããDAS25mgïŒml溶液ãïŒmlå ã
ïŒåé宀枩ã«ãŠæªæããããã®æº¶æ¶²ã液ãšã
ããå¥ã«ããããã€ããªããŒã²ã³200mgã
PBS300mlã«æº¶è§£ããããã®æº¶æ¶²ã液ãšããã
ïŒãïŒâã§ïŒ¡æ¶²3.5mlã液ã«å ããåã枩床ã§
çŽïŒæéæªæåå¿ããããæŽã«äžèšåå¿æº¶æ¶²ã«ã
æ°ŽçŽ åããŠçŽ ãããªãŠã 12.9mgãå ããçŽïŒæé
ïŒãïŒâã§æªæããªããéå ãè¡ã€ãã åå¿çµäºåŸãåŸããã溶液ããGLC溶液ã«å¯Ÿ
ããŠïŒãïŒâã§24æééæããã®ã¡ãããã«ã
GLC溶液ã溶åºå€ãšããŠã»ãã¢ããŒã¹4BïŒ4.4ïŒ
Ã50cmã«ã©ã ïŒãããŠæªåå¿è©Šè¬çãé€å»ããç®
çãšããéæŸå°æ§ãã€ãªã¢ãåŸãã ãã®æº¶æ¶²ãGLC溶液ã§åžéããŠãã€ããªããŒ
ã²ã³æ¿åºŠïŒmgïŒmlã«ããããã«30mMã«ãªããã
ã«ã¢ã¹ã³ã«ãã³é žãããªãŠã ãå ãããã®ïŒmlã
ãã€ã¢ã«ã«å泚ããã®ã¡ãåçµä¹Ÿç¥ãè¡ã€ãŠæŸå°
æ§èšºæå€èª¿è£œçšçµæç©ãåŸãã以äžã®æäœã¯å šãŠ
ç¡èçã«è¡ãªã€ãããã®å®æœäŸã§åŸãããæŸå°æ§
蚺æå€èª¿è£œçšçµæç©ã¯ç¶¿ç¶ã®åçµä¹Ÿç¥åã§ããã å®æœäŸ ïŒ ïŒâãªããœããã©ãŒã«ãã¹ïŒïŒ®âã¡ãã«ããªã»
ãã«ã«ããŸã³ïŒã«ã«ãã³é žïŒKTSïŒã»ãããµã³
ãžã¢ãã³ã®çž®åäœã®èª¿è£œ ïŒâãªããœããã©ãŒã«ãã¹ïŒïŒ®âã¡ãã«ããªã»
ãã«ã«ããŸã³ïŒã«ã«ãã³é žïŒä»¥äžãKTSïŒ132mg
ãç¡æ°Žãžãªããµã³ïŒmlã«æº¶è§£ãã10âä»è¿ã«å·åŽ
ããã®ã¡ãããªâïœâããã«ã¢ãã³0.12mlãæŽã«
ã€ãœããã«ã¯ãããã«ã ã¡ã€ã64ÎŒãå ããå
枩床ã§çŽ50åéæªæããŠãé žç¡æ°Žç©æ··å液ãåŸ
ãã å¥ã«ãâtertâããã«ãªãã·ã«ã«ããã«â
ïŒïŒïŒâãããµã³ãžã¢ãã³104mgãç¡æ°Žãžãªããµ
ã³ïŒmlã«æº¶è§£ããŠæº¶æ¶²ã調補ãããã®æº¶æ¶²ãæ··å
é žç¡æ°Žç©æº¶æ¶²ã«å ãã10âä»è¿ã§çŽ15æéæªæ
ããKTSââtertâããã«ãªãã·ã«ã«ããã«â
ïŒïŒïŒâãããµã³ãžã¢ãã³çž®åäœãåŸãããã®çž®
åäœæº¶æ¶²ã«æ¿å¡©é žãïŒãïŒæ»Žå ããŠPHïŒã«äžãã
ããšã«ãããã¢ããåºã®ä¿è·åºã§ããâtertâ
ããã«ãªãã·ã«ã«ããã«åºãã¯ãããç®çãšãã
KTSâãããµã³ãžã¢ãã³çž®åäœãåŸãããã®çž®
åäœã¯åé¢ããããšãªã次ã®åå¿ã«çšããã å®æœäŸ ïŒ éæŸå°æ§ãã€ãªã€ãŒããã³æŸå°æ§èšºæå€è£œé
çšã»çµæç©ã®è£œé (3) ïŒå®èœé äœåååç©ïŒKTSãããµã³ãžã¢ãã³
çž®åäœ çç掻æ§ååç©ïŒãããã€ããªããŒã²ã³ DAS200mgããžã¡ãã«ã¹ã«ããã·ãïŒmlã«æº¶è§£
ãããã®æº¶æ¶²ã«å®æœäŸïŒã§åŸãKTSâãããµã³
ãžã¢ãã³çž®åäœæº¶æ¶²ãå ãã宀枩ã§çŽïŒæéåå¿
ãããDASâãããµã³ãžã¢ãã³âKTSçž®åäœæº¶
液ãåŸãããã®æº¶æ¶²ïŒmlãããããã€ããªããŒã²
ã³250mgã溶解ãã50mlPBSïŒPHïŒ8.4ïŒã«å ããŠ
宀枩ã§çŽïŒæéæªæãåå¿ãããããã®åŸã圢æ
ãããã·ããå¡©åºãéå ããããæ°ŽçŽ åããŠçŽ ã
ããªãŠã 12.9mgãå ãçŽïŒæéæªæãç¶ããã åå¿çµäºåŸãåå¿æ¶²ãéåžžã®éæããŠãŒãã«å ¥
ããGLC溶液ã«å¯ŸããŠäžå€éæãè¡ã€ãŠæªåå¿
è©Šè¬çãè±å¡©çã«é€ããã éæåŸã溶åºå€ãšããŠGLC溶液ãçšããã»ã
ã¢ããŒã¹4BïŒ4.4ÏÃ50cmã«ã©ã ïŒã«ãããŠããã«
粟補ããç®çãšããéæŸå°æ§ãã€ãªã¢ãåŸãã 次ãã§ãã®æº¶æ¶²ãåçµä¹Ÿç¥ããããšã«ãã綿ç¶
ã®çµæ¶ãåŸããåŸãããçµæ¶100mgããçªçŽ ã¬ã¹
ãå¹ã蟌ãã§æº¶åé žçŽ ãé€å»ããæ°Ž160mlã«æº¶è§£
ãã1mMå¡©å第äžã¹ãºæ°Žæº¶æ¶²10mlãæŽã«ã¢ã¹ã³
ã«ãã³é žãããªãŠã 0.6ïœãå ãå®å šã«æº¶è§£ãã
ãã ãã®æº¶æ¶²ãååŸ0.22ÎŒïœã®ãã€ã«ã¿ãŒãéããŠ
1.5mlãã€ãçªçŽ 眮æãããã€ã¢ã«ã«å å¡«ããç®
çãšããæŸå°æ§èšºæå€èª¿è£œçšã®çµæç©ãåŸãã以
äžã®æäœã¯å šãŠç¡èçã«è¡ãªã€ããåŸãããæŸå°
æ§èšºæå€èª¿è£œçšçµæç©ã¯ãããèãæ·¡é»è²ã®æŸæ
ãªæ¶²ã§ããã å®æœäŸ ïŒ éæŸå°æ§ãã€ãªã¢äžã®ïŒå®èœé äœåååç©ã®å®
é DFOã¯ãFeïŒïŒãšïŒïŒïŒé¯äœã圢æãã極倧
åžå420nmãæãããDFOâFeïŒïŒé¯äœã®
420nmã«ãããåžå 床ïŒÎµmaxïŒã¯ã2.63Ã103ã§
ãã€ãã å®æœäŸïŒã§è£œé ããæŸå°æ§èšºæå€èª¿è£œçšã®çµæ
ç©ã泚å°çšèžçæ°ŽïŒä»¥äžãSPFæ°ŽïŒã«æº¶è§£ããã
ã€ããªããŒã²ã³æ¿åºŠïŒmgïŒmlãšããããã®æº¶æ¶²ã«
DFOãšFeïŒïŒãïŒïŒïŒé¯äœã圢æããã®ã«å å
ãªéã®å¡©å第äºé溶液ãå ããããã®æ··å溶液ã
ïŒæéé眮ããã®ã¡ãå¥ã«åæ§ãªæ¹æ³ã§SPFæ°Žã«
溶解ãã該çµæç©ãå¯Ÿç §æ¶²ãšããŠã420nmã«ãã
ãåžå 床ã枬å®ããã ãã®æ¹æ³ã«ããããã€ããªããŒã²ã³ïŒåååœã
ã®DFOéãæ±ãããšã15.2åã§ãã€ãã å®æœäŸ ïŒ éæŸå°æ§ãã€ãªã¢äžã®çç掻æ§ååç©ã®å®é é«é液äœã¯ãããã°ã©ãã€ãŒæ³ã«ãããéæŸå°
æ§ãã€ãªã¢äžã®ãã€ããªããŒã²ã³ã®å®éãè©Šã¿
ããã«ã©ã ã¯ãTSKâ3000SWãçšããïŒæº¶åªïŒ
0.05Mããªã¹â0.15Mé£å¡©ãå¡©é žç·©è¡æ¶²PH7.4ãå§
å100KgïŒcm2ãæµé1.0mlïŒminïŒã å®æœäŸïŒã®ç²Ÿè£œå·¥çšåã®å¯åå¿ç©ãå«ãåå¿æº¶
液ã«ãã¯ãšã³é žã¬ãªãŠã ãšããŠã¬ãªãŠã 1mCiã
å«ã溶液ãå ãæšèããã ãã®ã¬ãªãŠã â67æšè溶液ãäžèšæ¡ä»¶äžã§
HPLCã§åæãããæ€åºã¯ã¬ãªãŠã â67ã®æŸå°èœ
ã«ãã€ãã å®éšçµæã«ããã°ã溶åºãã¿ãŒã³ã¯ãã¬ãªãŠã
â67æšèã€ããã€ããªããŒã²ã³ããã³ã¬ãªãŠã â
67âDASâDFOã®ã»ãã«ã¬ãªãŠã â67âDFOã«
åž°å±ããïŒè ã®ããŒã¯ã瀺ãããã¬ãªãŠã â67â
DASâDFOã®ããŒã¯ãšã¬ãªãŠã â67âDFOã®ã
ãŒã¯ãšã®é¢ç©æ¯ãããDAS1ååãããã17.4å
ã®DFOãçµåãããŠããããšã確èªããããä»
æ¹ãåèšããããã«ãå®æœäŸïŒã®éæŸå°æ§ãã€ãª
ã¢äžã«å«ãŸããDFOéã¯ããã€ããªããŒã²ã³ïŒ
ååããã15.2åã§ããïŒå®æœäŸïŒïŒãåŸã€ãŠã
ãããã®æž¬å®å€ã«åºã¥ãDAS1ååãããã«çµå
ãããŠãããã€ããªããŒã²ã³ã®æ°ãç®åºãããšã
çŽ0.9åã§ãã€ãã å®æœäŸ ïŒ æŸå°æ§èšºæå€ã®è£œé (1) æŸå°æ§éå±ïŒã¬ãªãŠã â67 å®æœäŸïŒã§è£œé ããæŸå°æ§èšºæå€èª¿è£œçšã®çµæ
ç©ã«ãã¯ãšã³é žã¬ãªãŠã ãšããŠã¬ãªãŠã â67ã
2mCiãå«ã溶液ïŒmlãå ããŠãã¬ãªãŠã â67æš
èã€ãæŸå°æ§èšºæå€ãåŸãããã®å®æœäŸã§åŸãã
ãã¬ãªãŠã â67æšèã€ãæŸå°æ§èšºæå€ã¯ãããè
ãæ·¡é»è²ã®æŸæãªæº¶æ¶²ã§ãããPHã¯çŽ7.8ã§ããã å®æœäŸ ïŒ æŸå°æ§èšºæå€ã®è£œé (2) æŸå°æ§éå±ïŒãã¯ãããŠã â99m å®æœäŸïŒã§è£œé ããå¡©å第äžã¹ãºãå«æããæŸ
å°æ§èšºæå€èª¿è£œçšã®çµæç©1.5mlã«ãéãã¯ãã
ãŠã é žãããªãŠã ã®åœ¢ã§ãã¯ãããŠã â
99m3.3mCiãå«æããççé£å¡©æ°Ž1.5mlãå ããŠã
ãã¯ãããŠã â99mæšèã€ãæŸå°æ§èšºæå€ãåŸ
ãã以äžã®æäœã¯å šãŠç¡èçã«è¡ãªã€ãããã®å®
æœäŸã§åŸããããã¯ãããŠã â99mæšèã€ãæŸå°
æ§èšºæå€ã¯ãããèãæ·¡é»è²ã®æŸæãªæ¶²ã§ããã å®æœäŸ ïŒ ã¬ãªãŠã â67æšèã€ãæŸå°æ§èšºæå€ã®æšèçã®
æž¬å® å®æœäŸïŒã§è£œé ããã¬ãªãŠã â67æšèã€ãæŸå°
æ§èšºæå€ã«ã€ããŠãããããŒã«ç·©è¡æ¶²ïŒPHïŒ8.6ïŒ
ãå±é液ãšããã»ã«ããŒã¹ã¢ã»ããŒããæ³³åèãš
ããé»æ°æ³³åïŒ1.7mAïŒcm15åïŒãããªã€ãåŸã
ã©ãžãªã¯ãããã¹ãã€ããŒã§èµ°æ»ãããæŸå°èœ
ã¯ãåç·ããè² åŽã«0.5cmã®äœçœ®ã«åäžããŒã¯ãš
ããŠçŸããããã®æŸå°èœããŒã¯ã®äœçœ®ã¯ããã³ãœ
ãŒ3Rã«ãããããã€ããªããŒã²ã³ã®çºè²ãã³ã
ãšäžèŽããã 以äžã®çµæãããæ¬çºæã®ã¬ãªãŠã â67æšèã€
ãæŸå°æ§èšºæå€ã®æšèçã¯ãã»ãŒãŒ100ïŒ ã§ããã
ãã€ãã®é»è·ç¶æ ã«ã€ããŠããããã€ããªããŒã²
ã³ãšå·®ç°ãèªããªãã€ãã å®æœäŸ 10 ã¬ãªãŠã â67æšèã€ãæŸå°æ§èšºæå€ã®åå¡èœ å®æœäŸïŒã®æ¹æ³ã§è£œé ããã¬ãªãŠã â67æšèã€
ãæŸå°æ§èšºæå€ã«0.05ïŒ å¡©åã«ã«ã·ãŠã ãå«ã
0.1Mãžãšãã«ãã«ãããŒã«é žãããªãŠã å¡©é žç·©
è¡å€ïŒPH7.3ïŒãå ãããã€ããªããŒã²ã³æ¿åºŠãš
ããŠïŒmgïŒmlã«ãªãããã«èª¿æŽãããããã«ãã®
溶液ã«100unitïŒmlã®ããã³ãã³0.1mlãå ããæ°·
济äžã§30åéæŸçœ®ãããçæãããã€ããªã³åå¡
ãå®å šã«é€å»åŸããã€ããªã³åå¡ãšãã€ããªã³å
å¡ãé€å»ãã液äžã®æŸå°èœãèšæ°ããããšã«ãã
æ¬å€ã®åå¡èœã枬å®ããçµæãåºçºç©è³ªã§ããã
ããã€ããªããŒã²ã³ã«å¯ŸããŠ89ïŒ ã®åå¡èœã瀺ã
ãã å®æœäŸ 11 ã¬ãªãŠã â67æšèã€ãæŸå°æ§èšºæå€ã®ã©ããäœ
å ã«ãããæå å®æœäŸïŒã§è£œé ããã¬ãªãŠã â67æšèã€ãæŸå°
æ§èšºæå€0.2mlããšããè€æ°ã®S.D.ç³»éã©ããã«
éèå æäžããè¡äžæ¿åºŠã®çµæå€åããã³äœå å
åžæåã調ã¹ãã 第ïŒè¡šã«ãæäžçŽåŸããã®å枬å®æéã«ããã
åã蟌ã¿çã瀺ããã
å«æã»æŸå°æ§èšºæå€è£œé çšã®çµæç©ãããã³è©²ã
ã€ãªã€ãŒå«æã»æŸå°æ§èšºæå€ã«é¢ããããããé
æŸå°æ§ãã€ãªã€ãŒã¯ããžã¢ã«ããããã³ãã³ãä»
ãïŒå®èœé äœåååç©ãšçç掻æ§ååç©ãçµåã
ãŠãªããæç®æªèšèŒã®æ°èŠååç©ã§ããã æ¬çºæã®æŸå°æ§èšºæå€ã¯ãç¹å®èåšã®æåºãç¹
å®çŸæ£ã®æ€åºããã³çç掻æ§ååç©ã®åæ æ€æ»ãª
ã©ãç®çãšããæ žå»åŠççšéã«æçšã§ããã ïŒåŸæ¥ã®æè¡ïŒ çŸåšãé浞襲çæ žå»åŠèšºæã®ããã«çš®ã ã®æŸå°
æ§æšèååç©ãéçºãããæŸå°æ§èšºæå€ãšããŠèš
åºäžãã®æçšæ§ãé«ãèªããããŠãããäžè¬ã«ã
æŸå°æ§æšèååç©ã¯ãçäœå ãžã®å°å ¥åŸãç¹å®è
åšãç¹å®çŸæ£éšäœã«ç¹ç°çãªéç©æ§ã瀺ãããã
çäœå ã«ãããçççãªè«žç¶æ ã«å¯Ÿå¿ããç¹ç°ç
ãªåæ ããšãããšãèŠæ±ãããã æšèååç©ã«äœ¿çšãããæŸå°æ§éå±ãšããŠãåŸ
æ¥ãå ±æçµåã«ãããšãŒãâ131ã®ã»ãã«ãé äœ
çµåçã«ããæŸå°æ§éå±ãæ±çšãããããäŸã
ã°ããã¯ãããŠã â99ïœãã¬ãªãŠã â67ãã€ã³ãž
ãŠã â111çã§ãããããããã®æŸå°æ§éå±ã¯æ ž
å»åŠç蚺æã«ããé©ããç©æ§ã瀺ãããŸããæšè
ãããçç掻æ§ååç©ããŠããè¡æž ã¢ã«ããã³ã
ãã¬ãªãã€ã·ã³ããã€ããªããŒã²ã³ãªã©ãçšãã
ãããã«ãã¬ãªãŠã â67ãªã©ã®æŸå°æ§éå±ããçŽ
æ¥å°å ¥ããããšããè©Šã¿ããªãããŠããã ããããããã¯çç掻æ§ååç©ã®ãã¬ãŒã圢æ
æ§ã¯å¿ ããã倧ãããªãããŸã調補ãããæšèå
åç©ã®äœå æäžåŸã®å®å®æ§ãäœããããã«æŸå°èœ
ã®äœå æåãšãã®çç掻æ§ååç©ã®æåãäžèŽã
ãªãçãæ žå»åŠèšºæãç®çãšããçšéã«ãããŠã
æºè¶³ãã¹ããã®ã§ã¯ãªãã æ¬æ现æžã«ãããŠçšãããããçç掻æ§åå
ç©ããªãèªã¯ãç¹å®èåšãŸãã¯ç¹å®çŸæ£éšäœã«ç¹
ç°çãªéç©æ§ã瀺ãããçäœå ã«ãããçççãª
è«žç¶æ ã«å¯Ÿå¿ããç¹ç°çãªåæ ããšããããªãã®
ã§ãã€ãŠããã®äœå æåã远跡ããããšã«ããã
åçš®ã®èšºæã«æçšãªæ å ±ãæäŸãããååç©ãæ
å³ããããã®ãããªçç掻æ§ååç©ã«ãåªããç©
æ§ãæããæŸå°æ§éå±ãå®å®ã«ãããã該ååç©
ã®çç掻æ§ããããªãããšãªãå°å ¥ããããšãã§
ããã°ãæ žå»åŠèšºæã«ãããŠã極ããŠæçšãªçšé
ãæåŸ ããããè¿å¹ŽãïŒå®èœé äœåååç©ãçšã
ãæ¹æ³ãææ¡ãããã ããªãã¡ããããæ¹æ³ã¯ãïŒå®èœé äœåååç©
ã®åçš®éå±ã«å¯Ÿãã匷ããã¬ãŒã圢æèœãããã
é äœåååç©ã®æ«ç«¯åºïŒã¢ããåºããã³ã«ã«ãã
ã·ã«åºïŒã®çç掻æ§ååç©ã«å¯Ÿããåå¿æ§ãå©çš
ãã該æŸå°æ§éå±ãšè©²çç掻æ§ååç©ãããã®é
äœåååç©ãä»ããŠçµåãããããšãããªããã®
ã§ã該é äœåååç©ãšããŠãžãšãã¬ã³ããªã¢ãã³
äºé ¢é žïŒDTPAïŒããšãã¬ã³ãžã¢ãã³äžé ¢é ž
ïŒEDTAïŒãïŒâãªããœããã©ãŒã«ãã¹ïŒïŒ®âã¡
ãã«ããªã»ãã«ã«ããŸã³ïŒã«ã«ãã³é žããããšã
ããµãã³ãïŒâã¢ããã¡ãã¬ã³âïŒïŒïŒâãã³ã¿
ã³ãžãªã³ãã¹ïŒããªã»ãã«ã«ããŸã³ïŒèªå°äœãã
ã³ïŒâïŒïœâã¢ããã¢ã«ãã«ïŒããšãã«ãããã³
âïŒïŒïŒâãžãªã³âãã¹ïŒïŒ®âã¡ãã«ããªã»ãã«
ã«ããŸã³ïŒèªå°äœçãå ±åãããŠããïŒG.E.
KrejcarekïŒBiochemicalïŒBiophysical
Research Communication77 2.581â585
1977ïŒC.S.ïŒLeungïŒInt.J.Appl.RadiationïŒ
Isotope29 687â692 1978ãç¹éæ56â34634ã
ç¹éæ56â125317ãç¹éæ57â102820ãç¹é¡æ57
â157372åç §ïŒããããã®æ¹æ³ã«ããã°ããŸãïŒ
å®èœé äœåååç©ãšçç掻æ§ååç©ãçµåãããŠ
éæŸå°æ§ãã€ãªã€ãŒã調補ãããã®ãã€ãªã€ãŒã«
察ãæŸå°æ§éå±ãè£è¶³ãããŠãããåŸãããæšè
ååç©ã¯ãäžè¬çã«ã¯æ¯èŒçå®å®ã§ãã€ãŠçç掻
æ§ååç©ã®æŽ»æ§ãä¿æãããã®ã§ãããæ žå»åŠèšº
æã«ãããæŸå°æ§èšºæå€ãšããŠéåžžã«èå³ã®ãã
è¬å€ã§ããã ïŒçºæã解決ããããšãã課é¡ïŒ ããããªããããããå ¬ç¥ã®ãéæŸå°æ§ãã€ãª
ã€ãŒãçšããæŸå°æ§èšºæå€ã®æ倧ã®æ¬ ç¹ã¯ãçç
掻æ§ååç©ãšããŠãè¡æ 蚺æçšã®ãã€ããªããŒã²
ã³ïŒååéçŽ34äžïŒãã¬ã³èšºæçšã®å ç«ã°ãããª
ã³ïŒ§ïŒIgGïŒïŒååéçŽ16äžïŒã®ãããªãååéã®
倧ããªãã®ãçšããå Žåãçžå¯Ÿçã«éå±ã®å ãã
å²åãäœäžãããã®çµæã蚺æã«å¿ èŠãªæŸå°èœã¬
ãã«ãåŸãããªãããšã§ããã ãã®ïŒã€ã®è§£æ±ºæ³ãšããŠãçç掻æ§ååç©ïŒå
åã«å¯Ÿãå€æ°ã®ïŒå®èœé äœåååç©ãçµåããã
次ãã§ã§ãã®å€æ°ã®ïŒå®èœé äœååã ã«æŸå°æ§é
å±ãé äœãããããšã«ããé«æ¯æŸå°èœã®ãã®ãåŸ
ãæ¹æ³ãèãããããããããã®æ¹æ³ã¯ãçç掻
æ§ååç©ãå€æ§ãããããã®æŽ»æ§ãäœäžãæ¶æ» ã
ããçµæãšãªãã奜ãŸãããªããä»æ¹ãäžè¬ã«å
åéã®å€§ããçç掻æ§ååç©ãçšããå Žåããã®
æåæ§ã®èŠ³ç¹ãããã§ããã ãæäžéãå°éã«ã
ãããšãæãŸããŠããããã®ãã«ããåŸæ¥ããã®
éæŸå°æ§ãã€ãªã€ãŒã«ä»£ãããé«æ¯æŸå°èœã®æŸå°
æ§èšºæå€è£œé çšã»ååç©ã®åºçŸãæãŸããŠããã®
ã§ããã ïŒèª²é¡ã解決ããããã®ææ®µïŒ æ¬çºæè ãã¯ã以äžã®åé¡ç¹ã解決ãã¹ãçš®ã
ã®èŠ³ç¹ããæ€èšãå ããçµæããžã¢ã«ããããã³
ãã³ãšïŒå®èœé äœåååç©ãšçç掻æ§ååç©ãšã
ããªãæ°èŠãªååç©ã®éçºã«æåããã®ã§ããã ããªãã¡æ¬çºæã¯ã(1)å°ãªããïŒã€ã®éé¢ã¢ã«
ãããåºãæãããžã¢ã«ããããã³ãã³ïŒååãš
ã¢ããåºå«æïŒå®èœé äœåååç©å°ãªããšãïŒå
åãçµåããŠãªãå°ãªããšãïŒã€ã®éé¢ã¢ã«ãã
ãåºãæããåå¿æ§é«ååååç©ãšãã¢ããåºå«
æçç掻æ§ååç©ãšãããªãååç©ã§ãã€ãŠã該
ãžã¢ã«ããããã³ãã³ãšè©²ïŒå®èœé äœåã®çµååº
ããã³è©²ãžã¢ã«ããããã³ãã³ãšè©²çç掻æ§åå
ç©ã®çµååºããåã âCHïŒïŒ®âåºãŸãã¯âCH2
âNHâåºã§ããéæŸå°æ§ãã€ãªã€ãŒã(2)該ãã€
ãªã€ãŒå«ææŸå°æ§èšºæå€è£œé çšã®çµæç©ãããã³
(3)該ãã€ãªã€ãŒå«ææŸå°æ§èšºæå€ãæäŸãããã®
ã§ããã ãããæ°èŠãªéæŸå°æ§ãã€ãªã€ãŒãçšããã°ã
çç掻æ§ååç©ãå€æ§ããããã¯æŽ»æ§äœäžããã
ããšãªãé«æ¯æŸå°èœã®æŸå°æ§èšºæå€ã補é ããã
ãšãã§ããã ïŒäœçšïŒ æ¬çºæã®éæŸå°æ§ãã€ãªã¢ã¯ãçžå¯Ÿçã«å°æ°ã®
çç掻æ§ååç©ãšå€æ°ã®ïŒå®èœé äœåååç©ãã
ãžã¢ã«ããããã³ãã³ãä»ããŠçµåããååç©ã§
ãããïŒååãããå€æ°ã®éå±åœ¢æéšäœïŒé äœ
åïŒã該ïŒå®èœé äœåååç©éšåäžã«æãããã
ãªãã¡ã該ãã€ãªã€ãŒã¯ãïŒååã«å¯Ÿãçµåãã
ãæŸå°æ§éå±ã€ãªã³ã®æ°ããåã«ïŒå®èœé äœåå
åç©ãå°å ¥ããåŸæ¥ããã®ãã€ãªã¢ãšæ¯èŒãã
ãšãæ Œæ®µã«å€ãç¹ã§ç¹åŸŽä»ãããããããããã
ãæŸå°æ§éå±ãšçç掻æ§ååç©ããïŒã€ã®ååç©
ïŒïŒå®èœé äœåååç©ïŒãžã¢ã«ããããã³ãã³ïŒ
ãä»ããŠçµåããŠããããã該çç掻æ§ååç©ã®
å€æ§ã掻æ§äœäžãèµ·ããã«ãç®çãšããé«æ¯æŸå°
èœã®æŸå°æ§èšºæå€ãåŸãããšãã§ããã®ã§ããã ïŒçºæã®è©³èª¬ïŒ æ¬çºæã®éæŸå°æ§ãã€ãªã€ãŒã¯ããžã¢ã«ããã
ãã³ãã³ã®ã¢ã«ãããåºãïŒå®èœé äœåååç©ã
ãã³çç掻æ§ååç©ã®åã¢ããåºãšçµåããŠãª
ãã æ¬çºæã®å¥ã®æ æ§ã§ãã該æŸå°æ§èšºæå€è£œé çš
ã®çµæç©ã¯ãå¿ é æåãšããŠäžèšéæŸå°æ§ãã€ãª
ã€ãŒãå«æããã æ¬çºæã®ããïŒã€å¥ã®æ æ§ã§ããæŸå°æ§éå±æš
èã€ãæŸå°æ§èšºæå€ã¯ãå¿ é æåãšããŠäžèšéæŸ
å°æ§ãã€ãªã€ãŒãšæŸå°æ§éå±ãå«æããã æ¬çºæã«çšãããããžã¢ã«ããããã³ãã³ã¯ã
ãã³ãã³ãåæãšããŠéãšãŠçŽ é žçé©åœãªé žåå€
ã§é žåããããšã«ããäœããã代衚çã«ã¯åäœå
åäžã«å®èœåºãšããŠïŒã€ã®ã¢ã«ãããåºããã€é
ç¶é«ååã§ãããåžè²©ãããŠãããã®ã§ãããã
ã®å埩åäœæ°ã¯ãïŒã1000ã奜ãŸããã¯10ã500
ã§ããã æ¬çºæã«çšããããïŒå®èœé äœåååç©ã¯ã
çš®ã ã®æŸå°æ§éå±ãšã®åŒ·ããã¬ãŒã圢æèœãšã¢ã«
ãããåºãšç©åãªæ¡ä»¶äžã§çµåããèœåãæãã
ã¢ããåºãæã€ååç©ã§ã§ããã°ããããã§ãã
ãããŸãããããã¢ããåºã«ä»£ããŠã«ã«ããã·ã«
åºãæã€ååç©ã«ãããŠãããã®ã«ã«ããã·ã«åº
ããããµã³ãžã¢ãã³çã«ããã¢ããåºã«å€ããã¢
ã«ãããåºãšç©åãªæ¡ä»¶ã§çµåããèœåãæãã
ãããšã«ãããæ¬çºæã«äœ¿çšããããšãã§ããã
ãããïŒå®èœé äœåååç©ãšããŠãäŸãã°ããã
ãšãããµãã³ãïŒâã¢ããã¡ãã¬ã³âïŒïŒïŒâã
ã³ã¿ã³ãžãªã³âãã¹ïŒããªã»ã«ã«ã«ããŸã³ïŒèªå°
äœãïŒâïŒïœâã¢ããã¢ã«ãã«ïŒããšãã«ããã
ã³âïŒïŒïŒâãžãªã³âãã¹ïŒããªã»ãã«ã«ããŸ
ã³ïŒèªå°äœçã®æ«ç«¯ã¢ããåºå«æïŒå®èœé äœåå
åç©ãªãã³ã«ããžãšãã¬ã³ããªã¢ãã³äºé ¢é ž
ïŒDTPAïŒããšãã¬ã³ãžã¢ãã³äžé ¢é žïŒEDTAïŒã
ïŒâãªããœããã©ãŒã«ãã¹ïŒïŒ®âã¡ãã«ããªã»ã
ã«ã«ããŸã³ïŒã«ã«ãã³é žã®ãããªæ«ç«¯ã¢ããåºå«
æååç©ã«èªå°å¯èœãªïŒå®èœé äœåååç©ãæã
ãããã æ¬çºæã®ã¢ããåºå«æïŒå®èœé äœåååç©ã¯ã
ãããã¢ããåºããžã¢ã«ããããã³ãã³ã®ã¢ã«ã
ããåºãšãâCHïŒïŒ®âåºãŸãã¯âCH2âNHâåº
ãä»ããŠçµåããããžã¢ã«ããããã³ãã³ïŒåå
ã«å¯ŸããŠçµåããïŒå®èœé äœåååç©ã®ååæ°
ã¯ãïŒä»¥äžã代衚çã«ã¯ïŒä»¥äžã奜ãŸããã¯10以
äžã§ããã æ¬çºæã«çšããããçç掻æ§ååç©ã¯ãç¹å®è
åšãŸãã¯ç¹å®çŸæ£éšäœã«ç¹ç°ãªéç©æ§ã瀺ãããŸ
ãã¯ãçäœå ã«ãããçççãªè«žç¶æ ã«å¯Ÿå¿ãã
ç¹ç°ãªåæ ããšãããã®äœå æåã远跡ããããš
ã«ãããåçš®ã®èšºæã«æçšãªæ å ±ãæäŸããããš
ãæåŸ ããããããªååç©ã§ãããç¹ã«ãæ¬çºæ
ã®å®çšæ§ãèæ ®ãããšãååéçŽ10äžä»¥äžã®çç
掻æ§ååç©ã«ãããŠããã®æçšæ§ã奜é©ã«çºæ®ã
ããã該ååç©ãšããŠãäŸãã°ãããè¡æž ã¢ã«ã
ãã³ããã€ããªããŒã²ã³ããŠããããŒãŒãå ç«æ
äœã§ããIgGã®åŠãã¿ã³ãã¯ããã¬ãªãã€ã·ã³ã
ã«ããã€ã·ã³ã®åŠãæçç©è³ªããã«ã¢ã³é¡ãç³
é¡ãèèªé žããã³ãããã®èªå°äœãæããããã ãŸããã¢ããåºãæããªãçç掻æ§ååç©ã®å Ž
åã«ã¯ãé©åœãªæ¹æ³ã«ããã¢ããåºãå°å ¥ããã
ãšã«ãããæ¬çºæã®çç掻æ§ååç©ãšããŠäœ¿çšã§
ããã æ¬çºæã®ã¢ããåºå«æçç掻æ§ååç©ã¯ããã
ãã¢ããåºããžã¢ã«ããããã³ãã³ã®ã¢ã«ããã
åºãšãâCHïŒïŒ®âåºãŸãã¯âCH2âNHâåºãä»
ããŠçµåããããžã¢ã«ããããã³ãã³ïŒååã«å¯Ÿ
ããŠçµåããçç掻æ§ååç©ã®ååæ°ã¯ã奜ãŸã
ãã¯ãå°ãªããšã10以äžããã奜ãŸããïŒä»¥äžã«
ãã¹ãã§ããã æ¬çºæã«äœ¿çšãããæŸå°æ§éå±ã¯ãæ žå»åŠèšºæ
ã«é©ããç©ççç¹æ§ãæããïŒå®èœé äœåååç©
ãšå®å®ãªãã¬ãŒãã圢æããæŸå°æ§éå±ã§ããã°
ãããäŸãã°ãã¬ãªãŠã â67ãã¬ãªãŠã â68ãã€
ã³ãžãŠã â111ãã¿ãªãŠã â201ããã¯ãããŠã â
99mãªã©ãçŸåšãæ žå»åŠåéã§æ±çšãããŠããæŸ
å°æ§éå±ãæããããšãã§ããããã ããéãã¯
ãããŠã é žå¡©ã®åœ¢ã§åžè²©ãããŠãããã¯ãããŠã
â99mãªã©ã®æŸå°æ§éå±ã€ãªã³ã®ããã«ãå ¥æã
ããŸãŸã®åå䟡ç¶æ ã§ã¯åè¿°ã®ïŒå®èœé äœååå
ç©ãšåŒ·åºã«çµåããªãå Žåããã®ãããªæŸå°æ§é
å±ã€ãªã³ãã匷åºãªçµåã®åœ¢æã«æå©ãªäœåå䟡
ç¶æ ã«éå ãããã«éåžžçšããããŠãã第äžã¹ãº
å¡©çã®éå å€ãããããããæ¬çºæã«ããæŸå°æ§
蚺æå€èª¿è£œçšã®çµæç©äžã«å«æãããŠããã°æ¬çº
æãå®æœãããã 次ã«ãæ¬çºæã®éæŸå°æ§ãã€ãªã€ãŒã®è£œé ã«ã€
ããŠã¯ããžã¢ã«ããããã³ãã³ã®ã¢ã«ãããåº
ãšãïŒå®èœé äœåååç©ããã³çç掻æ§ååç©ã®
ã¢ããåºãåå¿ãããŠç®çç©ãåŸãããšãã§ãã
ããããã«ããã®åå¿çæç©ãæ°ŽçŽ åããŠçŽ ãã
ãªãŠã ã®ãããªéå å€ã§éå ããããšã«ãã€ãŠã
åŸãããšãã§ããããžã¢ã«ããããã³ãã³ãšåå¿
ãããïŒå®èœé äœåååç©ããã³çç掻æ§ååç©
ã®åå¿ã®é çªã¯ä»»æã§ããããŸãåå¿ã®äžéã«ã
ããŠäžèšéå æäœããããããšãã§ããããã
ã«ã段éçåå¿ã®å Žåãå段éåå¿ã®çµäºæã«äž
éäœã®åé¢ã粟補æäœãå ããããšãä»»æã§ã
ããåå¿çµäºåŸã該çç掻æ§ååç©ã®ååŠçãç©
çã«å¿ããŠãã«ã©ã ã¯ãããã°ã©ãæ³ãã²ã«ãé
æ³ããã³éææ³ãªã©ã®ä»»æã®æ¹æ³ã«ãã粟補ãã
ããšãã§ããã 次ã«ã以äžã®åå¿çµè·¯ã«åŸããæ¬çºæã®éæŸå°
æ§ãã€ãªã€ãŒã®ä»£è¡šçãªè£œæ³ã説æããã åŒäžãããã³ïŒ¹ã¯ãããããïŒå®èœé äœåå
åç©ããã³çç掻æ§ååç©ã®ã¢ããåºåå¿æ®åºã
ã¯âCHOãŸãã¯âCH2OHãïœã¯ïŒã1000ã®æŽ
æ°ãïœããã³ïœã¯ãããããïŒã1000ã®æŽæ°ãïœ
ããã³ïœã¯ãããããïŒã1000ã®æŽæ°ã§ãããã
ã ããïœïŒïœããã³ïœïŒïœïŒïœã¯ïŒã1000ã§ã
ãã äžèšåå¿çµè·¯ã§ã¯ãçŽéç¶ã®éæŸå°æ§ãã€ãªã¢
ã®ã¿ã瀺ããããçç掻æ§ååç©ãæ«ç«¯ã¢ããåº
ãïŒå以äžæã€å Žåããã®çç掻æ§ååç©ãæ¶æ©
ç©è³ªãšãªããããªæ¶æ©é«ååååç©ãå¯çããã
ãã®æ¶æ©é«ååååç©ãæ¬çºæã®å®æœãäœã劚ã
ãªãããŸããæ¬çºæã®éæŸå°æ§ãã€ãªã€ãŒã«ãã
ãŠãçç掻æ§ååç©ãšïŒå®èœé äœåååç©ã®çµå
ç¶æ ã¯ããžã¢ã«ããããã³ãã³ãä»ããéæ¥çãª
çµåã§ãããããã®çµåã«å ããŠãçŽæ¥çãªçµå
ãããããååç©ååç©ã®çç掻æ§ãæãªããªã
éãã蚱容ããããã®ã§ããã 次ã«ãæ¬çºæã®ç¬¬ïŒã®æ æ§ã§ããæŸå°æ§èšºæå€
調補çšçµæç©ã®è£œé æ³ã«ã€ããŠè¿°ã¹ããæ¬çµæç©
ã¯ãåèšã®æ¹æ³ã«ããåŸãããéæŸå°æ§ãã€ãªã¢
ãç¡èæ°Žãççé£å¡©æ¶²ãå皮緩è¡æ¶²ã«æº¶è§£ããã
ãšã«ãã調補ãããããŸããå¿ èŠã«å¿ããéæŸå°
æ§ãã€ãªã¢ã®æº¶è§£æ§ãå¢ãããã®ææ©æº¶åªãPHã
調補ãããã®é žãå¡©åºã®æ·»å ãæŸå°æ§éå±ã€ãªã³
ã®åå䟡ç¶æ ã調æŽãããã®éå å€ãŸãã¯é žåå€
ã®æ·»å ãããã³å®å®åå€ãç匵åå€ãä¿åå€ã®æ·»
å ãããŠãããããããéå å€ã¯ãè¬å€åŠäžèš±å®¹
ããã氎溶æ§éå å€ã䜿çšããããã奜ãŸããã¯
第äžã¹ãºå¡©ãæãããããæ¬çºæã®å®æœã«ãããŠ
æçšãªç¬¬äžã¹ãºå¡©ã¯ãäºäŸ¡ã®ã¹ãºã圢æããå¡©ã§
ãã€ãŠãå ·äœçã«ã¯äŸãã°ãå¡©çŽ ã€ãªã³ãããçŽ
ã€ãªã³ãªã©ã®ããã²ã³é°ã€ãªã³ãç¡«é žã€ãªã³ãç¡
é žã€ãªã³ãªã©ã®è€çŽ ç¡æ©é žæ®åºã€ãªã³ãé ¢é žã€ãª
ã³ãã¯ãšã³é žã€ãªã³ãªã©ã®ææ©é žæ®åºã€ãªã³ãšåœ¢
æããå¡©ãèšãã éæŸå°æ§ãã€ãªã¢ã®éã¯ãæçµçã«è£œé ããã
æŸå°æ§èšºæå€ã®æšèçãå®çšäžæ¯éã®ãªãçšåºŠã«
é«ããªããããªéã§ããã°ããããã€è¬å€åŠäžèš±
容ãããç¯å²ã§ããããšãæãŸããããšã¯ãããŸ
ã§ããªãããŸããææã«ããå ãããã第äžã¹ãº
å¡©çã®éå å€ã«ã€ããŠã¯ãæŸå°æ§éå±ã€ãªã³ãé©
åœãªåå䟡ç¶æ ã«éå ããã®ã«å åãªéã§ããã
ãè¬å€åŠäžèš±å®¹ãããç¯å²ã§ããã°ããã åŸãããéæŸå°æ§çµæç©ã¯ããã®ãŸãŸæº¶æ¶²ã®åœ¢
ã§æŸå°æ§éå±ã«ããæšèåã«äŸããŠãããããŸ
ããåçµä¹Ÿç¥æ³ãŸãã¯äœæž©å§èžçºæ³ãªã©ã®æ¹æ³ã«
ãã溶åªãé€å»ãã也ç¥åã®åœ¢ã«ããåŸãæŸå°æ§
éå±ã«ããæšèåã«äŸããŠãããã æåŸã«ãæ¬çºæã®ç¬¬ïŒã®æ æ§ã§ããæŸå°æ§èšºæ
å€ã®è£œé æ³ã説æãããããã¯ãåèšã®éæŸå°æ§
ãã€ãªã¢ãŒãšæŸå°æ§éå±ãå«ã溶液ãæ¥è§Šããã
ããšãããªãã極ããŠç°¡åãªæäœã«ããã該蚺æ
å€ã補é ãããšãã§ããã æ¥è§ŠãããæŸå°æ§éå±ã®æŸå°èœã¯ä»»æã§ãã
ããç®çãšããæ žå»åŠèšºæãå®æœããã«éããŠã
å åãªæ å ±ãåŸããããããªæŸå°èœã§ãããã
ã€ã被éšè ã®æŸå°ç·è¢«æãå¯èœãªéãäœãããã
ããªæŸå°èœã®ç¯å²ã§ããããšãæãŸããã®ã¯ãã
ãŸã§ããªãã 該蚺æå€ã®æäžæ¹æ³ã«ã€ããŠã¯ãäžè¬ã«éèå
ãæäžãè¡ãªãããããæšèãããã¹ãçç掻æ§
ååç©ã®æäžåŸãã®æŽ»æ§ãçºçŸãããã«æå©ãªæ
äžæ¹æ³ã§ããã°ãããä»ã®æäžæ¹æ³ãå®æœããã
ãšãã§ããã ïŒå®æœäŸïŒ ã€ãã«å®æœäŸãæããŠãæ¬çºæãããã«è©³ãã
説æãããããããã«éå®ããããã®ã§ã¯ãªãã å®æœäŸ ïŒ éæŸå°æ§ãã€ãªã€ãŒããã³æŸå°æ§èšºæå€è£œé
çšã»çµæç©ã®è£œé (1) ïŒå®èœé äœåååç©ïŒãããšãããµãã³ïŒDFOïŒ çç掻æ§ååç©ïŒãããã€ããªããŒã²ã³ DFO130mgãPH8.4ã®0.01Mãªã³é žç·©è¡æ¶²â
0.15Mé£å¡©æ°Žæ··å溶液ïŒä»¥äžãPBSïŒ1.5mlã«æº¶
解ããããã®æº¶æ¶²ã«ãããªãšãã«ã¢ãã³ïŒ99ïŒ æº¶
液ïŒ27.9ÎŒãå ããçŽïŒåé宀枩ã§æªæããã
ããã«ããã®æº¶æ¶²ã«ãæ°Žã«æº¶è§£ãããžã¢ã«ããã
ãã³ãã³ïŒDASïŒ25mgïŒml溶液ãïŒmlå ãã15
åé宀枩ã§æªæããããã®æº¶æ¶²ã液ãšããã å¥ã«ããããã€ããªããŒã²ã³200mgãPBS30ml
ã«æº¶è§£ããããã®æº¶æ¶²ã液ãšãããïŒãïŒâã§
液3.5mlã液ã«å ããåã枩床ã§çŽïŒæéæª
æãåå¿ãããã åå¿çµäºåŸãåŸããã溶液ãã0.01MãããŠç³
â0.3Mã¯ãšã³é žãããªãŠã 溶液ïŒä»¥äžGLC溶液ïŒ
ã«å¯ŸããŠïŒãïŒâã§24æééæããã®ã¡ããã
ã«ãGLC溶液ã溶åºå€ãšããŠã»ãã¢ããŒã¹4B
ïŒ4.4ÏÃ50cmã«ã©ã ïŒã«ãããŠãæªåå¿è©Šè¬çã
é€å»ããç®çãšããéæŸå°æ§ãã€ãªã¢ãåŸãã ãã®æº¶æ¶²ãGLC溶液ã§åžéããŠãã€ããªããŒ
ã²ã³æ¿åºŠïŒmgïŒmlãšããããã«30mMã«ãªããã
ã«ã¢ã¹ã³ã«ãã³é žãããªãŠã ãå ãããã®ïŒmlã
ãã€ã¢ã«ã«å泚ããã®ã¡ãåçµä¹Ÿç¥ãè¡ã€ãŠæŸå°
æ§èšºæå€è£œé çšã®çµæç©ãåŸãã以äžã®æäœã¯å š
ãŠç¡èçã«è¡ãªã€ããåŸãããæŸå°æ§èšºæå€è£œé
çšã®çµæç©ã¯ç¶¿ç¶ã®åçµä¹Ÿç¥åã§ããã å®æœäŸ ïŒ éæŸå°æ§ãã€ãªã€ãŒããã³æŸå°æ§èšºæå€è£œé
çšã»çµæç©ã®è£œé (2) ïŒå®èœé äœåååç©ïŒDFO çç掻æ§ååç©ïŒãããã€ããªããŒã²ã³ DFO130mgãPBS1.5mlã«æº¶è§£ããããã®æº¶æ¶²
ã«ãããªãšãã«ã¢ãã³ïŒ99ïŒ æº¶æ¶²ïŒ27.9ÎŒãå
ããçŽïŒåé宀枩ã§æªæãããããã«ããã®æº¶æ¶²
ã«ãæ°Žã«æº¶è§£ããDAS25mgïŒml溶液ãïŒmlå ã
ïŒåé宀枩ã«ãŠæªæããããã®æº¶æ¶²ã液ãšã
ããå¥ã«ããããã€ããªããŒã²ã³200mgã
PBS300mlã«æº¶è§£ããããã®æº¶æ¶²ã液ãšããã
ïŒãïŒâã§ïŒ¡æ¶²3.5mlã液ã«å ããåã枩床ã§
çŽïŒæéæªæåå¿ããããæŽã«äžèšåå¿æº¶æ¶²ã«ã
æ°ŽçŽ åããŠçŽ ãããªãŠã 12.9mgãå ããçŽïŒæé
ïŒãïŒâã§æªæããªããéå ãè¡ã€ãã åå¿çµäºåŸãåŸããã溶液ããGLC溶液ã«å¯Ÿ
ããŠïŒãïŒâã§24æééæããã®ã¡ãããã«ã
GLC溶液ã溶åºå€ãšããŠã»ãã¢ããŒã¹4BïŒ4.4ïŒ
Ã50cmã«ã©ã ïŒãããŠæªåå¿è©Šè¬çãé€å»ããç®
çãšããéæŸå°æ§ãã€ãªã¢ãåŸãã ãã®æº¶æ¶²ãGLC溶液ã§åžéããŠãã€ããªããŒ
ã²ã³æ¿åºŠïŒmgïŒmlã«ããããã«30mMã«ãªããã
ã«ã¢ã¹ã³ã«ãã³é žãããªãŠã ãå ãããã®ïŒmlã
ãã€ã¢ã«ã«å泚ããã®ã¡ãåçµä¹Ÿç¥ãè¡ã€ãŠæŸå°
æ§èšºæå€èª¿è£œçšçµæç©ãåŸãã以äžã®æäœã¯å šãŠ
ç¡èçã«è¡ãªã€ãããã®å®æœäŸã§åŸãããæŸå°æ§
蚺æå€èª¿è£œçšçµæç©ã¯ç¶¿ç¶ã®åçµä¹Ÿç¥åã§ããã å®æœäŸ ïŒ ïŒâãªããœããã©ãŒã«ãã¹ïŒïŒ®âã¡ãã«ããªã»
ãã«ã«ããŸã³ïŒã«ã«ãã³é žïŒKTSïŒã»ãããµã³
ãžã¢ãã³ã®çž®åäœã®èª¿è£œ ïŒâãªããœããã©ãŒã«ãã¹ïŒïŒ®âã¡ãã«ããªã»
ãã«ã«ããŸã³ïŒã«ã«ãã³é žïŒä»¥äžãKTSïŒ132mg
ãç¡æ°Žãžãªããµã³ïŒmlã«æº¶è§£ãã10âä»è¿ã«å·åŽ
ããã®ã¡ãããªâïœâããã«ã¢ãã³0.12mlãæŽã«
ã€ãœããã«ã¯ãããã«ã ã¡ã€ã64ÎŒãå ããå
枩床ã§çŽ50åéæªæããŠãé žç¡æ°Žç©æ··å液ãåŸ
ãã å¥ã«ãâtertâããã«ãªãã·ã«ã«ããã«â
ïŒïŒïŒâãããµã³ãžã¢ãã³104mgãç¡æ°Žãžãªããµ
ã³ïŒmlã«æº¶è§£ããŠæº¶æ¶²ã調補ãããã®æº¶æ¶²ãæ··å
é žç¡æ°Žç©æº¶æ¶²ã«å ãã10âä»è¿ã§çŽ15æéæªæ
ããKTSââtertâããã«ãªãã·ã«ã«ããã«â
ïŒïŒïŒâãããµã³ãžã¢ãã³çž®åäœãåŸãããã®çž®
åäœæº¶æ¶²ã«æ¿å¡©é žãïŒãïŒæ»Žå ããŠPHïŒã«äžãã
ããšã«ãããã¢ããåºã®ä¿è·åºã§ããâtertâ
ããã«ãªãã·ã«ã«ããã«åºãã¯ãããç®çãšãã
KTSâãããµã³ãžã¢ãã³çž®åäœãåŸãããã®çž®
åäœã¯åé¢ããããšãªã次ã®åå¿ã«çšããã å®æœäŸ ïŒ éæŸå°æ§ãã€ãªã€ãŒããã³æŸå°æ§èšºæå€è£œé
çšã»çµæç©ã®è£œé (3) ïŒå®èœé äœåååç©ïŒKTSãããµã³ãžã¢ãã³
çž®åäœ çç掻æ§ååç©ïŒãããã€ããªããŒã²ã³ DAS200mgããžã¡ãã«ã¹ã«ããã·ãïŒmlã«æº¶è§£
ãããã®æº¶æ¶²ã«å®æœäŸïŒã§åŸãKTSâãããµã³
ãžã¢ãã³çž®åäœæº¶æ¶²ãå ãã宀枩ã§çŽïŒæéåå¿
ãããDASâãããµã³ãžã¢ãã³âKTSçž®åäœæº¶
液ãåŸãããã®æº¶æ¶²ïŒmlãããããã€ããªããŒã²
ã³250mgã溶解ãã50mlPBSïŒPHïŒ8.4ïŒã«å ããŠ
宀枩ã§çŽïŒæéæªæãåå¿ãããããã®åŸã圢æ
ãããã·ããå¡©åºãéå ããããæ°ŽçŽ åããŠçŽ ã
ããªãŠã 12.9mgãå ãçŽïŒæéæªæãç¶ããã åå¿çµäºåŸãåå¿æ¶²ãéåžžã®éæããŠãŒãã«å ¥
ããGLC溶液ã«å¯ŸããŠäžå€éæãè¡ã€ãŠæªåå¿
è©Šè¬çãè±å¡©çã«é€ããã éæåŸã溶åºå€ãšããŠGLC溶液ãçšããã»ã
ã¢ããŒã¹4BïŒ4.4ÏÃ50cmã«ã©ã ïŒã«ãããŠããã«
粟補ããç®çãšããéæŸå°æ§ãã€ãªã¢ãåŸãã 次ãã§ãã®æº¶æ¶²ãåçµä¹Ÿç¥ããããšã«ãã綿ç¶
ã®çµæ¶ãåŸããåŸãããçµæ¶100mgããçªçŽ ã¬ã¹
ãå¹ã蟌ãã§æº¶åé žçŽ ãé€å»ããæ°Ž160mlã«æº¶è§£
ãã1mMå¡©å第äžã¹ãºæ°Žæº¶æ¶²10mlãæŽã«ã¢ã¹ã³
ã«ãã³é žãããªãŠã 0.6ïœãå ãå®å šã«æº¶è§£ãã
ãã ãã®æº¶æ¶²ãååŸ0.22ÎŒïœã®ãã€ã«ã¿ãŒãéããŠ
1.5mlãã€ãçªçŽ 眮æãããã€ã¢ã«ã«å å¡«ããç®
çãšããæŸå°æ§èšºæå€èª¿è£œçšã®çµæç©ãåŸãã以
äžã®æäœã¯å šãŠç¡èçã«è¡ãªã€ããåŸãããæŸå°
æ§èšºæå€èª¿è£œçšçµæç©ã¯ãããèãæ·¡é»è²ã®æŸæ
ãªæ¶²ã§ããã å®æœäŸ ïŒ éæŸå°æ§ãã€ãªã¢äžã®ïŒå®èœé äœåååç©ã®å®
é DFOã¯ãFeïŒïŒãšïŒïŒïŒé¯äœã圢æãã極倧
åžå420nmãæãããDFOâFeïŒïŒé¯äœã®
420nmã«ãããåžå 床ïŒÎµmaxïŒã¯ã2.63Ã103ã§
ãã€ãã å®æœäŸïŒã§è£œé ããæŸå°æ§èšºæå€èª¿è£œçšã®çµæ
ç©ã泚å°çšèžçæ°ŽïŒä»¥äžãSPFæ°ŽïŒã«æº¶è§£ããã
ã€ããªããŒã²ã³æ¿åºŠïŒmgïŒmlãšããããã®æº¶æ¶²ã«
DFOãšFeïŒïŒãïŒïŒïŒé¯äœã圢æããã®ã«å å
ãªéã®å¡©å第äºé溶液ãå ããããã®æ··å溶液ã
ïŒæéé眮ããã®ã¡ãå¥ã«åæ§ãªæ¹æ³ã§SPFæ°Žã«
溶解ãã該çµæç©ãå¯Ÿç §æ¶²ãšããŠã420nmã«ãã
ãåžå 床ã枬å®ããã ãã®æ¹æ³ã«ããããã€ããªããŒã²ã³ïŒåååœã
ã®DFOéãæ±ãããšã15.2åã§ãã€ãã å®æœäŸ ïŒ éæŸå°æ§ãã€ãªã¢äžã®çç掻æ§ååç©ã®å®é é«é液äœã¯ãããã°ã©ãã€ãŒæ³ã«ãããéæŸå°
æ§ãã€ãªã¢äžã®ãã€ããªããŒã²ã³ã®å®éãè©Šã¿
ããã«ã©ã ã¯ãTSKâ3000SWãçšããïŒæº¶åªïŒ
0.05Mããªã¹â0.15Mé£å¡©ãå¡©é žç·©è¡æ¶²PH7.4ãå§
å100KgïŒcm2ãæµé1.0mlïŒminïŒã å®æœäŸïŒã®ç²Ÿè£œå·¥çšåã®å¯åå¿ç©ãå«ãåå¿æº¶
液ã«ãã¯ãšã³é žã¬ãªãŠã ãšããŠã¬ãªãŠã 1mCiã
å«ã溶液ãå ãæšèããã ãã®ã¬ãªãŠã â67æšè溶液ãäžèšæ¡ä»¶äžã§
HPLCã§åæãããæ€åºã¯ã¬ãªãŠã â67ã®æŸå°èœ
ã«ãã€ãã å®éšçµæã«ããã°ã溶åºãã¿ãŒã³ã¯ãã¬ãªãŠã
â67æšèã€ããã€ããªããŒã²ã³ããã³ã¬ãªãŠã â
67âDASâDFOã®ã»ãã«ã¬ãªãŠã â67âDFOã«
åž°å±ããïŒè ã®ããŒã¯ã瀺ãããã¬ãªãŠã â67â
DASâDFOã®ããŒã¯ãšã¬ãªãŠã â67âDFOã®ã
ãŒã¯ãšã®é¢ç©æ¯ãããDAS1ååãããã17.4å
ã®DFOãçµåãããŠããããšã確èªããããä»
æ¹ãåèšããããã«ãå®æœäŸïŒã®éæŸå°æ§ãã€ãª
ã¢äžã«å«ãŸããDFOéã¯ããã€ããªããŒã²ã³ïŒ
ååããã15.2åã§ããïŒå®æœäŸïŒïŒãåŸã€ãŠã
ãããã®æž¬å®å€ã«åºã¥ãDAS1ååãããã«çµå
ãããŠãããã€ããªããŒã²ã³ã®æ°ãç®åºãããšã
çŽ0.9åã§ãã€ãã å®æœäŸ ïŒ æŸå°æ§èšºæå€ã®è£œé (1) æŸå°æ§éå±ïŒã¬ãªãŠã â67 å®æœäŸïŒã§è£œé ããæŸå°æ§èšºæå€èª¿è£œçšã®çµæ
ç©ã«ãã¯ãšã³é žã¬ãªãŠã ãšããŠã¬ãªãŠã â67ã
2mCiãå«ã溶液ïŒmlãå ããŠãã¬ãªãŠã â67æš
èã€ãæŸå°æ§èšºæå€ãåŸãããã®å®æœäŸã§åŸãã
ãã¬ãªãŠã â67æšèã€ãæŸå°æ§èšºæå€ã¯ãããè
ãæ·¡é»è²ã®æŸæãªæº¶æ¶²ã§ãããPHã¯çŽ7.8ã§ããã å®æœäŸ ïŒ æŸå°æ§èšºæå€ã®è£œé (2) æŸå°æ§éå±ïŒãã¯ãããŠã â99m å®æœäŸïŒã§è£œé ããå¡©å第äžã¹ãºãå«æããæŸ
å°æ§èšºæå€èª¿è£œçšã®çµæç©1.5mlã«ãéãã¯ãã
ãŠã é žãããªãŠã ã®åœ¢ã§ãã¯ãããŠã â
99m3.3mCiãå«æããççé£å¡©æ°Ž1.5mlãå ããŠã
ãã¯ãããŠã â99mæšèã€ãæŸå°æ§èšºæå€ãåŸ
ãã以äžã®æäœã¯å šãŠç¡èçã«è¡ãªã€ãããã®å®
æœäŸã§åŸããããã¯ãããŠã â99mæšèã€ãæŸå°
æ§èšºæå€ã¯ãããèãæ·¡é»è²ã®æŸæãªæ¶²ã§ããã å®æœäŸ ïŒ ã¬ãªãŠã â67æšèã€ãæŸå°æ§èšºæå€ã®æšèçã®
æž¬å® å®æœäŸïŒã§è£œé ããã¬ãªãŠã â67æšèã€ãæŸå°
æ§èšºæå€ã«ã€ããŠãããããŒã«ç·©è¡æ¶²ïŒPHïŒ8.6ïŒ
ãå±é液ãšããã»ã«ããŒã¹ã¢ã»ããŒããæ³³åèãš
ããé»æ°æ³³åïŒ1.7mAïŒcm15åïŒãããªã€ãåŸã
ã©ãžãªã¯ãããã¹ãã€ããŒã§èµ°æ»ãããæŸå°èœ
ã¯ãåç·ããè² åŽã«0.5cmã®äœçœ®ã«åäžããŒã¯ãš
ããŠçŸããããã®æŸå°èœããŒã¯ã®äœçœ®ã¯ããã³ãœ
ãŒ3Rã«ãããããã€ããªããŒã²ã³ã®çºè²ãã³ã
ãšäžèŽããã 以äžã®çµæãããæ¬çºæã®ã¬ãªãŠã â67æšèã€
ãæŸå°æ§èšºæå€ã®æšèçã¯ãã»ãŒãŒ100ïŒ ã§ããã
ãã€ãã®é»è·ç¶æ ã«ã€ããŠããããã€ããªããŒã²
ã³ãšå·®ç°ãèªããªãã€ãã å®æœäŸ 10 ã¬ãªãŠã â67æšèã€ãæŸå°æ§èšºæå€ã®åå¡èœ å®æœäŸïŒã®æ¹æ³ã§è£œé ããã¬ãªãŠã â67æšèã€
ãæŸå°æ§èšºæå€ã«0.05ïŒ å¡©åã«ã«ã·ãŠã ãå«ã
0.1Mãžãšãã«ãã«ãããŒã«é žãããªãŠã å¡©é žç·©
è¡å€ïŒPH7.3ïŒãå ãããã€ããªããŒã²ã³æ¿åºŠãš
ããŠïŒmgïŒmlã«ãªãããã«èª¿æŽãããããã«ãã®
溶液ã«100unitïŒmlã®ããã³ãã³0.1mlãå ããæ°·
济äžã§30åéæŸçœ®ãããçæãããã€ããªã³åå¡
ãå®å šã«é€å»åŸããã€ããªã³åå¡ãšãã€ããªã³å
å¡ãé€å»ãã液äžã®æŸå°èœãèšæ°ããããšã«ãã
æ¬å€ã®åå¡èœã枬å®ããçµæãåºçºç©è³ªã§ããã
ããã€ããªããŒã²ã³ã«å¯ŸããŠ89ïŒ ã®åå¡èœã瀺ã
ãã å®æœäŸ 11 ã¬ãªãŠã â67æšèã€ãæŸå°æ§èšºæå€ã®ã©ããäœ
å ã«ãããæå å®æœäŸïŒã§è£œé ããã¬ãªãŠã â67æšèã€ãæŸå°
æ§èšºæå€0.2mlããšããè€æ°ã®S.D.ç³»éã©ããã«
éèå æäžããè¡äžæ¿åºŠã®çµæå€åããã³äœå å
åžæåã調ã¹ãã 第ïŒè¡šã«ãæäžçŽåŸããã®å枬å®æéã«ããã
åã蟌ã¿çã瀺ããã
ãè¡šã
ãè¡šã
第ïŒè¡šã«ããã°ãæ¬çºæã®ã¬ãªãŠã â67æšèã€
ãæŸå°æ§èšºæå€ã¯ãé·æéã«ããã極ããŠé«ãè¡
äžæ¿åºŠããã³ä»ã®èåšãžã®è¯å¥œãªååžã瀺ããã
ããã¯ãåŸæ¥ã®ãšãŒãâ131æšèãã€ããªããŒã²
ã³ã®äœå ååžãšã»ãŒåçã§ããã å®æœäŸ 12 ã¬ãªãŠã â67âæšèã€ãæŸå°æ§èšºæå€ã®æ è¡æ
ãŠãµã®äœå ã«ãããæå 家å ã®å€§è ¿éèéšã«ãã«ããªã³å¡åžæ³ã«ããã
è¡æ ãçæãããããã®å®¶å ã«ãå®æœäŸïŒã§è£œé
ããã¬ãªãŠã â67æšèã€ãæŸå°æ§èšºæå€0.5mlãã
è³éèããæäžãããæäžåŸ24æéåŸã«ãäžå®é
ã®è¡æ¶²ãæ¡åãããã ã¡ã«è¡æ éšäœãæåºããã
ãããæ¡åããè¡æ¶²ããã³è¡æ éšäœãè©Šæãšãã
äž¡è ã®æŸå°èœãèšæž¬ãããäž¡è ã®åäžééäžã«å«
ãŸããæŸå°èœæ¯ïŒè¡æ éšäœïŒè¡æ¶²ïŒã¯8.63±3.83
ïŒ10å¹ã®å¹³åå€Â±S.D.å€ïŒã§ãã€ãã ãã®å®æœäŸãããã³å®æœäŸïŒããã³11ã®çµæã
ããæ¬çºæã®èšºæå€ã¯ãã€ããªããŒã²ã³ã®çç掻
æ§ãã»ãŒãã®ãŸãŸä¿æããŠãããè¡æ æ€åºãç®ç
ãšããæ žå»åŠèšºæã«æ¥µããŠæçšã§ããããšãå€æ
ããã å®æœäŸ 13 ãã¯ãããŠã â99mæšèã€ãæŸå°æ§èšºæå€ã®æš
èçã®æž¬å® å®æœäŸïŒã§åŸããã¯ãããŠã â99mæšèã€ãæŸ
å°æ§èšºæå€ã®æšèçããå®æœäŸïŒãšåæ§ã®æ¹æ³ã§
枬å®ãããšãããã»ãŒ100ïŒ ã§ããããã€ãã®é»
è·ç¶æ ã«ã€ããŠããããã€ããªããŒã²ã³ãšå·®ç°ã
èªããªãã€ãã å®æœäŸ 14 ãã¯ãããŠã â99mæšèã€ãæŸå°æ§èšºæå€ã®å
å¡èœ å®æœäŸïŒã§åŸããã¯ãããŠã â99mæšèã€ãæŸ
å°æ§èšºæå€ã®åå¡èœããå®æœäŸ10ãšåæ§ã®æ¹æ³ã§
枬å®ãããšãããåºçºç©è³ªã§ãããããã€ããªã
ãŒã²ã³ã«å¯ŸããŠ91ïŒ ã®åå¡èœã瀺ããã å®æœäŸ 15 æ¬çºæã®æŸå°æ§èšºæå€ã®æšèèœã«ã€ããŠã®æ¯èŒ
å®éš å®æœäŸïŒã§è£œé ããæŸå°æ§èšºæå€è£œé çšã®çµæ
ç©ã«SPFæ°Žãå ããŠæº¶è§£ãããã€ããªããŒã²ã³é
ãšããŠ0.5ã0.75ã1.0ã1.5ã2.0ãããã³3.0mgã«
çžåœãã溶éãå¥ã®ãã€ã¢ã«ã«ãšãããããã
ã«ãã¬ãªãŠã â67ãšããŠ1mCiãå«ãã¯ãšã³é žã¬
ãªãŠã ïŒmlãå ããããããã®è©Šæã宀枩ã«ãŠïŒ
æéæŸçœ®ããåŸãå®æœäŸïŒã®æ¹æ³ã§æšèçã枬å®
ããããŸãå¯Ÿç §ãšããŠãDFOãçŽæ¥ãã€ããªã
ãŒã²ã³ã«çµåãããååç©ãçšãããã¬ãªãŠã â
67æšèãã€ããªããŒã²ã³ã«ã€ããŠããåæ§ã®æ¹æ³
ã§ãã®æšèçã枬å®ãããçµæã第ïŒè¡šã«ç€ºãã
ãæŸå°æ§èšºæå€ã¯ãé·æéã«ããã極ããŠé«ãè¡
äžæ¿åºŠããã³ä»ã®èåšãžã®è¯å¥œãªååžã瀺ããã
ããã¯ãåŸæ¥ã®ãšãŒãâ131æšèãã€ããªããŒã²
ã³ã®äœå ååžãšã»ãŒåçã§ããã å®æœäŸ 12 ã¬ãªãŠã â67âæšèã€ãæŸå°æ§èšºæå€ã®æ è¡æ
ãŠãµã®äœå ã«ãããæå 家å ã®å€§è ¿éèéšã«ãã«ããªã³å¡åžæ³ã«ããã
è¡æ ãçæãããããã®å®¶å ã«ãå®æœäŸïŒã§è£œé
ããã¬ãªãŠã â67æšèã€ãæŸå°æ§èšºæå€0.5mlãã
è³éèããæäžãããæäžåŸ24æéåŸã«ãäžå®é
ã®è¡æ¶²ãæ¡åãããã ã¡ã«è¡æ éšäœãæåºããã
ãããæ¡åããè¡æ¶²ããã³è¡æ éšäœãè©Šæãšãã
äž¡è ã®æŸå°èœãèšæž¬ãããäž¡è ã®åäžééäžã«å«
ãŸããæŸå°èœæ¯ïŒè¡æ éšäœïŒè¡æ¶²ïŒã¯8.63±3.83
ïŒ10å¹ã®å¹³åå€Â±S.D.å€ïŒã§ãã€ãã ãã®å®æœäŸãããã³å®æœäŸïŒããã³11ã®çµæã
ããæ¬çºæã®èšºæå€ã¯ãã€ããªããŒã²ã³ã®çç掻
æ§ãã»ãŒãã®ãŸãŸä¿æããŠãããè¡æ æ€åºãç®ç
ãšããæ žå»åŠèšºæã«æ¥µããŠæçšã§ããããšãå€æ
ããã å®æœäŸ 13 ãã¯ãããŠã â99mæšèã€ãæŸå°æ§èšºæå€ã®æš
èçã®æž¬å® å®æœäŸïŒã§åŸããã¯ãããŠã â99mæšèã€ãæŸ
å°æ§èšºæå€ã®æšèçããå®æœäŸïŒãšåæ§ã®æ¹æ³ã§
枬å®ãããšãããã»ãŒ100ïŒ ã§ããããã€ãã®é»
è·ç¶æ ã«ã€ããŠããããã€ããªããŒã²ã³ãšå·®ç°ã
èªããªãã€ãã å®æœäŸ 14 ãã¯ãããŠã â99mæšèã€ãæŸå°æ§èšºæå€ã®å
å¡èœ å®æœäŸïŒã§åŸããã¯ãããŠã â99mæšèã€ãæŸ
å°æ§èšºæå€ã®åå¡èœããå®æœäŸ10ãšåæ§ã®æ¹æ³ã§
枬å®ãããšãããåºçºç©è³ªã§ãããããã€ããªã
ãŒã²ã³ã«å¯ŸããŠ91ïŒ ã®åå¡èœã瀺ããã å®æœäŸ 15 æ¬çºæã®æŸå°æ§èšºæå€ã®æšèèœã«ã€ããŠã®æ¯èŒ
å®éš å®æœäŸïŒã§è£œé ããæŸå°æ§èšºæå€è£œé çšã®çµæ
ç©ã«SPFæ°Žãå ããŠæº¶è§£ãããã€ããªããŒã²ã³é
ãšããŠ0.5ã0.75ã1.0ã1.5ã2.0ãããã³3.0mgã«
çžåœãã溶éãå¥ã®ãã€ã¢ã«ã«ãšãããããã
ã«ãã¬ãªãŠã â67ãšããŠ1mCiãå«ãã¯ãšã³é žã¬
ãªãŠã ïŒmlãå ããããããã®è©Šæã宀枩ã«ãŠïŒ
æéæŸçœ®ããåŸãå®æœäŸïŒã®æ¹æ³ã§æšèçã枬å®
ããããŸãå¯Ÿç §ãšããŠãDFOãçŽæ¥ãã€ããªã
ãŒã²ã³ã«çµåãããååç©ãçšãããã¬ãªãŠã â
67æšèãã€ããªããŒã²ã³ã«ã€ããŠããåæ§ã®æ¹æ³
ã§ãã®æšèçã枬å®ãããçµæã第ïŒè¡šã«ç€ºãã
ãè¡šã
第ïŒè¡šã«ç€ºãããšããæ¬çºæã®ååç©ã«ããé
æŸå°æ§ãã€ãªã¢ã¯ããã€ããªããŒã²ã³ïŒmgã䜿çš
ããå Žåãå®çšçãªæšèæéã§ããïŒæéã«ãã
ãŠã1mCiã®ã¬ãªãŠã â67ã100ïŒ æšèããããšã
ã§ãããããã«å¯Ÿããå¯Ÿç §ã§ã¯ãåæ§ã®æ¡ä»¶äžã§
17.0ïŒ ããæšèãåŸãªãã°ããã§ãªãã25.1mgã
ã®å€éã®ãã€ããªããŒã²ã³ãçšããŠã83.5ïŒ ãã
æšèããããšãã§ããªãã以äžã®çµæãããæ¬çº
æã®ååç©ã䜿çšããããšã«ãããé«æ¯æŸå°èœã®
ã¬ãªãŠã â67æšèãã€ããªããŒã²ã³èªå°äœã補é
ããããšãã§ãããã€ããã®æšèäœã¯è¡æ ã®æ€åº
ãç®çãšããæ žå»åŠèšºæã®çšéã«æ¥µããŠé©ããã
ã®ã§ããããšã蚌æãããã å®æœäŸ 16 æ¬çºæã®æŸå°æ§èšºæå€ã®æ¯æ§å®éš å®æœäŸïŒã§åŸãã¬ãªãŠã â67æšèã€ãæŸå°æ§èšº
æå€ããæŸå°èœãé©åºŠã«æžè¡°ãããåŸãS.D.ç³»é
éã©ããåïŒå¹ã®å矀ã«å¯Ÿãäœé100ïœãããïŒ
mlïŒäºå®ããŠãã人äœæäžéã®600åã«çžåœïŒãã
ãŸãICRç³»ééããŠã¹åïŒå¹ã®å矀ã«å¯Ÿãäœé
1.0ïœããã0.5mlïŒäºå®ããŠãã人äœæäžéã®
3000åïŒããããããéèå æäžãããå¥ã«å¯Ÿç §
矀ããŠãåæ°ã®ååç©çŸ€ã«å¯Ÿãå容éã®ççé£å¡©
æ°Žãéèå æäžããã以äžã®ååç©ã10æ¥é飌è²
ããæ¯æ¥äœéå€åãèšé²ãããäœéå€åã«ãã
ãŠãæŸå°æ§èšºæå€ãæäžãã矀ãšå¯Ÿç §çŸ€ã®éã«ã¯
ææã®å·®ã¯èªããããªãã€ãã10æ¥éã®é£Œè²èŠ³å¯
ã®åŸããã¹ãŠã®åç©ã解åããåèåšã«ã€ããŠç°
åžžã®æç¡ã芳å¯ããããç°åžžãèªããåç©ã¯ãªã
ã€ããããªãã¡æ¬çºæã®èšºæå€ã¯ãäºå®ããŠãã
人äœæäžéã®600ããã³ã3000åã®çšéã§ïŒçš®é¡
ã®å®éšåç©ã«æäžããå Žåã«ãããŠãå šãç°åžžã¯
èªããããªãã€ãã
æŸå°æ§ãã€ãªã¢ã¯ããã€ããªããŒã²ã³ïŒmgã䜿çš
ããå Žåãå®çšçãªæšèæéã§ããïŒæéã«ãã
ãŠã1mCiã®ã¬ãªãŠã â67ã100ïŒ æšèããããšã
ã§ãããããã«å¯Ÿããå¯Ÿç §ã§ã¯ãåæ§ã®æ¡ä»¶äžã§
17.0ïŒ ããæšèãåŸãªãã°ããã§ãªãã25.1mgã
ã®å€éã®ãã€ããªããŒã²ã³ãçšããŠã83.5ïŒ ãã
æšèããããšãã§ããªãã以äžã®çµæãããæ¬çº
æã®ååç©ã䜿çšããããšã«ãããé«æ¯æŸå°èœã®
ã¬ãªãŠã â67æšèãã€ããªããŒã²ã³èªå°äœã補é
ããããšãã§ãããã€ããã®æšèäœã¯è¡æ ã®æ€åº
ãç®çãšããæ žå»åŠèšºæã®çšéã«æ¥µããŠé©ããã
ã®ã§ããããšã蚌æãããã å®æœäŸ 16 æ¬çºæã®æŸå°æ§èšºæå€ã®æ¯æ§å®éš å®æœäŸïŒã§åŸãã¬ãªãŠã â67æšèã€ãæŸå°æ§èšº
æå€ããæŸå°èœãé©åºŠã«æžè¡°ãããåŸãS.D.ç³»é
éã©ããåïŒå¹ã®å矀ã«å¯Ÿãäœé100ïœãããïŒ
mlïŒäºå®ããŠãã人äœæäžéã®600åã«çžåœïŒãã
ãŸãICRç³»ééããŠã¹åïŒå¹ã®å矀ã«å¯Ÿãäœé
1.0ïœããã0.5mlïŒäºå®ããŠãã人äœæäžéã®
3000åïŒããããããéèå æäžãããå¥ã«å¯Ÿç §
矀ããŠãåæ°ã®ååç©çŸ€ã«å¯Ÿãå容éã®ççé£å¡©
æ°Žãéèå æäžããã以äžã®ååç©ã10æ¥é飌è²
ããæ¯æ¥äœéå€åãèšé²ãããäœéå€åã«ãã
ãŠãæŸå°æ§èšºæå€ãæäžãã矀ãšå¯Ÿç §çŸ€ã®éã«ã¯
ææã®å·®ã¯èªããããªãã€ãã10æ¥éã®é£Œè²èŠ³å¯
ã®åŸããã¹ãŠã®åç©ã解åããåèåšã«ã€ããŠç°
åžžã®æç¡ã芳å¯ããããç°åžžãèªããåç©ã¯ãªã
ã€ããããªãã¡æ¬çºæã®èšºæå€ã¯ãäºå®ããŠãã
人äœæäžéã®600ããã³ã3000åã®çšéã§ïŒçš®é¡
ã®å®éšåç©ã«æäžããå Žåã«ãããŠãå šãç°åžžã¯
èªããããªãã€ãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ å°ãªããšãïŒã€ã®éé¢ã¢ã«ãããåºãæãã
ãžã¢ã«ããããã³ãã³ïŒååãšã¢ããåºå«æïŒå®
èœé äœåååç©å°ãªããšãïŒååãçµåããŠãªã
å°ãªããšãïŒã€ã®éé¢ã¢ã«ãããåºãæããåå¿
æ§é«ååååç©ãšã ã¢ããåºå«æçç掻æ§ååç©ãšãããªãååç©
ã§ãã€ãŠã該ãžã¢ã«ããããã³ãã³ãšè©²ïŒå®èœé
äœåã®çµååºããã³è©²ãžã¢ã«ããããã³ãã³ãšè©²
çç掻æ§ååç©ã®çµååºããåã âCHïŒïŒ®âåº
ãŸãã¯âCH2âNHâåºã§ããéæŸå°æ§ãã€ãªã€
ãŒã ïŒ ãžã¢ã«ããããã³ãã³ã®å埩åäœæ°ãïŒã
1000ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®éæŸå°æ§
ãã€ãªã€ãŒã ïŒ çç掻æ§ååç©ã®ååéãçŽ10äžä»¥äžã§ãã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ãŸãã¯ç¬¬ïŒé èšèŒã®éæŸå°
æ§ãã€ãªã€ãŒã ïŒ çç掻æ§ååç©ãããããã€ããªããŒã²ã³ãŸ
ãã¯å ç«ã°ãããªã³ïŒ§ã§ãã€ãŠãïŒå®èœé äœåå
åç©ãããããšãããµãã³ãŸãã¯ïŒâãªããœãã
ã©ãŒã«ãã¹ïŒïŒ®âã¡ãã«ããªã»ãã«ã«ããŸã³ïŒã«
ã«ãã³é žã®ã¢ãã³èªå°äœã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé ã第ïŒé ã®ïŒã€ã«èšèŒã®éæŸå°æ§ãã€ãªã€
ãŒã ïŒ ãžã¢ã«ããããã³ãã³ã«ã¢ããåºå«æïŒå®èœ
é äœåååç©ãçž®åãããŠéå ããã®ã¡ã¢ããåº
å«æçç掻æ§ååç©ãçž®åãããŠãªãäžèšååç©
ãå«ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã第ïŒé ã®ïŒã€ã«èš
èŒã®éæŸå°æ§ãã€ãªã€ãŒã ïŒ ãžã¢ã«ããããã³ãã³ã«ã¢ããåºå«æçç掻
æ§ååç©ãçž®åãããŠéå ããã®ã¡ã¢ããåºå«æ
ïŒå®èœé äœåååç©ãçž®åãããŠãªãäžèšååç©
ãå«ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã第ïŒé ã®ïŒã€ã«èš
èŒã®éæŸå°æ§ãã€ãªã€ãŒã ïŒ å¿ é æåãšããŠã å°ãªããšãïŒã€ã®éé¢ã¢ã«ãããåºãæãããž
ã¢ã«ããããã³ãã³ïŒååãšã¢ããåºå«æïŒå®èœ
é äœåååç©ïŒåå以äžãçµåããŠãªãå°ãªããš
ãïŒã€ä»¥äžã®æªå€æéé¢ã¢ã«ãããåºãæããå
å¿æ§é«ååååç©ãšã ã¢ããåºå«æçç掻æ§ååç©ãšãããªãååç©
ã§ãã€ãŠã該ãžã¢ã«ããããã³ãã³ãšè©²ïŒå®èœé
äœåã®çµååºããã³è©²ãžã¢ã«ããããã³ãã³ãšè©²
çç掻æ§ååç©ã®çµååºããåã âCHïŒïŒ®âåº
ãŸãã¯âCH2âNHâåºã§ããéæŸå°æ§ãã€ãªã€
㌠ãå«æããæŸå°æ§éå±æšèã€ãæŸå°æ§èšºæå€ã»è£œ
é çšã®çµæç©ã ïŒ å¿ é æåãšããŠã å°ãªããšãïŒã€ã®éé¢ã¢ã«ãããåºãæãããž
ã¢ã«ããããã³ãã³ïŒååãšã¢ããåºå«æïŒå®èœ
é äœåååç©ïŒåå以äžãçµåããŠãªãå°ãªããš
ãïŒã€ä»¥äžã®æªå€æéé¢ã¢ã«ãããåºãæããå
å¿æ§é«ååååç©ãšã ã¢ããåºå«æçç掻æ§ååç©ãšãããªãååç©
ã§ãã€ãŠã該ãžã¢ã«ããããã³ãã³ãšè©²ïŒå®èœé
äœåã®çµååºããã³è©²ãžã¢ã«ããããã³ãã³ãšè©²
çç掻æ§ååç©ã®çµååºããåã âCHïŒïŒ®âåº
ãŸãã¯âCH2âNHâåºã§ããéæŸå°æ§ãã€ãªã€
ãŒãšæŸå°æ§éå±ãšãå«æããæŸå°æ§éå±æšèã€ã
æŸå°æ§èšºæå€ã
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57215858A JPS59106425A (ja) | 1982-12-08 | 1982-12-08 | é«ååååç©å«ææŸå°æ§èšºæå€ |
| US06/558,333 US4666697A (en) | 1982-12-08 | 1983-12-05 | Radioactive diagnostic agent |
| AU22219/83A AU565287B2 (en) | 1982-12-08 | 1983-12-08 | Radioactive diagnostic agent, and non-radioactive carriers therefor |
| EP83112331A EP0111311B1 (en) | 1982-12-08 | 1983-12-08 | Non-radioactive carriers and radioactive diagnostic agent |
| KR1019830005819A KR860000843B1 (ko) | 1982-12-08 | 1983-12-08 | ë°©ì¬ì± ì§ëšì ë° ê·žë¥Œ ìí ë¹ ë°©ì¬ì± ëŽì²Žì ì ì¡°ë°©ë² |
| DE8383112331T DE3382191D1 (de) | 1982-12-08 | 1983-12-08 | Nicht-radioaktive traeger und radiodiagnostisches mittel. |
| CA000442833A CA1252087A (en) | 1982-12-08 | 1983-12-08 | Radioactive diagnostic agent, and non-radioactive carriers therefor |
| US06/947,093 US5077389A (en) | 1982-12-08 | 1986-12-29 | Chemical product usable as a non-radioactive carrier |
| CA000570616A CA1258850A (en) | 1982-12-08 | 1988-06-28 | Radioactive chemical product for use as a diagnostic agent |
| CA000570612A CA1258851A (en) | 1982-12-08 | 1988-06-28 | Chemical product useful as a non-radioactive carrier |
| US08/215,671 US5384401A (en) | 1982-12-08 | 1994-03-22 | Chemical product usable as a non-radioactive carrier |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57215858A JPS59106425A (ja) | 1982-12-08 | 1982-12-08 | é«ååååç©å«ææŸå°æ§èšºæå€ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59106425A JPS59106425A (ja) | 1984-06-20 |
| JPH047329B2 true JPH047329B2 (ja) | 1992-02-10 |
Family
ID=16679434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57215858A Granted JPS59106425A (ja) | 1982-12-08 | 1982-12-08 | é«ååååç©å«ææŸå°æ§èšºæå€ |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59106425A (ja) |
-
1982
- 1982-12-08 JP JP57215858A patent/JPS59106425A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59106425A (ja) | 1984-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4855353A (en) | High molecular compounds having amino groups, and their utilization | |
| US4666697A (en) | Radioactive diagnostic agent | |
| US5118798A (en) | Radioactive metallic element-labelled high molecular compound useful in nuclear medicine | |
| US5310536A (en) | Ligands for improving metal chelate formation kinetics | |
| JPH036124B2 (ja) | ||
| JPH0233692B2 (ja) | ||
| JPS641449B2 (ja) | ||
| CA2066031C (en) | Methods for reducing non-target retention of immunoconjugates and metabolites thereof | |
| JPH047329B2 (ja) | ||
| JPH0414084B2 (ja) | ||
| JP2548711B2 (ja) | ã¢ããåºãšïŒå®èœæ§é äœåãæããåå¿æ§é«ååååç©ãšãã®å©çš | |
| JP2677543B2 (ja) | çç掻æ§ç©è³ªçµåé«ååååç©ããã³åœè©²ååç©ãå«ãæŸå°æ§å»è¬å調補çšãã£ãªã¢ãŒ | |
| JPH0421682B2 (ja) | ||
| JP2677544B2 (ja) | æŸå°æ§éå±å çŽ çµåé«ååååç©ããã³åœè©²ååç©ãå«ãæŸå°æ§å»è¬å | |
| CA1258851A (en) | Chemical product useful as a non-radioactive carrier | |
| JPH0460974B2 (ja) | ||
| JPH0345723B2 (ja) | ||
| JPH0433767B2 (ja) | ||
| JPH0615478B2 (ja) | æŸå°æ§å»è¬åãšãã®èª¿è£œçšé«ååååç© | |
| JPH0759524B2 (ja) | æŸå°æ§å»è¬åãšãã®èª¿è£œçšé«ååååç© |